| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC6A18 GABRE SLC25A24 GPM6A CACNA1C ABCC3 ABCA4 SLC4A7 CHRNA9 HCN4 HCN1 PIEZO1 SLC43A1 PKD1L1 TMEM63C SLCO1B3 ABCA8 OPRM1 SLC6A11 SLC8A2 PIEZO2 SLC12A4 P2RX5 SCN1A SLC16A14 SCN2A SCN3A SLC22A5 SCN4A SCN7A SCN8A SCN9A SCN10A ABCD4 SERINC3 ANO3 SLC25A48 | 3.94e-19 | 1180 | 108 | 37 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | SLC6A18 GABRE SLC25A24 GPM6A CACNA1C ABCC3 ABCA4 SLC4A7 CHRNA9 HCN4 HCN1 PIEZO1 SLC43A1 PKD1L1 TMEM63C SLCO1B3 ABCA8 OPRM1 SLC6A11 SLC8A2 PIEZO2 SLC12A4 P2RX5 SCN1A SLC16A14 SCN2A SCN3A SLC22A5 SCN4A SCN7A SCN8A SCN9A SCN10A ABCD4 SERINC3 ANO3 SLC25A48 | 7.29e-18 | 1289 | 108 | 37 | GO:0005215 |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 6.91e-17 | 26 | 108 | 10 | GO:0005248 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | GPM6A CACNA1C CHRNA9 HCN4 HCN1 PIEZO1 PKD1L1 TMEM63C OPRM1 PIEZO2 P2RX5 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A | 2.92e-14 | 343 | 108 | 19 | GO:0005261 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | GABRE GPM6A CACNA1C CHRNA9 HCN4 HCN1 PIEZO1 PKD1L1 TMEM63C OPRM1 PIEZO2 P2RX5 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A ANO3 | 4.82e-14 | 459 | 108 | 21 | GO:0005216 |
| GeneOntologyMolecularFunction | channel activity | GABRE GPM6A CACNA1C CHRNA9 HCN4 HCN1 PIEZO1 PKD1L1 TMEM63C OPRM1 PIEZO2 SLC12A4 P2RX5 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A ANO3 | 6.65e-14 | 525 | 108 | 22 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | GABRE GPM6A CACNA1C CHRNA9 HCN4 HCN1 PIEZO1 PKD1L1 TMEM63C OPRM1 PIEZO2 SLC12A4 P2RX5 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A ANO3 | 6.91e-14 | 526 | 108 | 22 | GO:0022803 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC6A18 GABRE GPM6A CACNA1C SLC4A7 CHRNA9 HCN4 HCN1 PIEZO1 PKD1L1 TMEM63C OPRM1 SLC6A11 SLC8A2 PIEZO2 SLC12A4 P2RX5 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A ANO3 | 7.86e-14 | 793 | 108 | 26 | GO:0015075 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC6A18 GPM6A CACNA1C SLC4A7 CHRNA9 HCN4 HCN1 PIEZO1 PKD1L1 TMEM63C OPRM1 SLC6A11 SLC8A2 PIEZO2 SLC12A4 P2RX5 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A | 1.04e-13 | 664 | 108 | 24 | GO:0008324 |
| GeneOntologyMolecularFunction | sodium channel activity | 1.83e-13 | 52 | 108 | 10 | GO:0005272 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC6A18 GABRE SLC25A24 GPM6A CACNA1C ABCC3 SLC4A7 CHRNA9 HCN4 HCN1 PKD1L1 TMEM63C OPRM1 SLC6A11 SLC8A2 SLC12A4 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A ANO3 | 2.26e-13 | 758 | 108 | 25 | GO:0015318 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | SLC6A18 SLC4A7 HCN4 HCN1 SLC6A11 SLC8A2 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A | 4.63e-13 | 171 | 108 | 14 | GO:0015081 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC6A18 GPM6A CACNA1C SLC4A7 CHRNA9 HCN4 HCN1 PKD1L1 OPRM1 SLC6A11 SLC8A2 SLC12A4 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A | 6.51e-13 | 465 | 108 | 20 | GO:0046873 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC6A18 GPM6A CACNA1C SLC4A7 CHRNA9 HCN4 HCN1 PKD1L1 TMEM63C OPRM1 SLC6A11 SLC8A2 SLC12A4 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A | 1.87e-11 | 627 | 108 | 21 | GO:0022890 |
| GeneOntologyMolecularFunction | gated channel activity | GABRE CACNA1C CHRNA9 HCN4 HCN1 PIEZO1 TMEM63C OPRM1 PIEZO2 P2RX5 SCN1A SCN2A SCN7A SCN10A ANO3 | 3.53e-10 | 334 | 108 | 15 | GO:0022836 |
| GeneOntologyMolecularFunction | sodium ion binding | 8.12e-09 | 14 | 108 | 5 | GO:0031402 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 2.53e-07 | 26 | 108 | 5 | GO:0031420 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC6A18 SLC25A24 ABCC3 ABCA4 SLC4A7 SLCO1B3 ABCA8 SLC6A11 SLC8A2 SLC12A4 SLC16A14 SLC22A5 ABCD4 | 1.83e-06 | 477 | 108 | 13 | GO:0022804 |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 4.18e-06 | 171 | 108 | 8 | GO:0015103 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 6.61e-06 | 182 | 108 | 8 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 7.17e-06 | 184 | 108 | 8 | GO:0022832 | |
| GeneOntologyMolecularFunction | GTPase activity | 1.63e-05 | 341 | 108 | 10 | GO:0003924 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 1.81e-05 | 151 | 108 | 7 | GO:0008509 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC25A24 ABCC3 SLC4A7 SLC43A1 SLCO1B3 SLC6A11 SLC16A14 ABCD4 SERINC3 | 3.07e-05 | 293 | 108 | 9 | GO:0008514 |
| GeneOntologyMolecularFunction | GDP phosphatase activity | 3.27e-05 | 12 | 108 | 3 | GO:0004382 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC6A18 SLC25A24 SLC4A7 SLCO1B3 SLC6A11 SLC8A2 SLC12A4 SLC16A14 SLC22A5 | 3.32e-05 | 296 | 108 | 9 | GO:0015291 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 8.65e-05 | 193 | 108 | 7 | GO:0015276 | |
| GeneOntologyMolecularFunction | phosphothreonine residue binding | 8.66e-05 | 3 | 108 | 2 | GO:0050816 | |
| GeneOntologyMolecularFunction | 6-phosphofructokinase activity | 8.66e-05 | 3 | 108 | 2 | GO:0003872 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 9.84e-05 | 197 | 108 | 7 | GO:0022834 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 9.90e-05 | 17 | 108 | 3 | GO:0099508 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 1.29e-04 | 90 | 108 | 5 | GO:0008028 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 1.34e-04 | 207 | 108 | 7 | GO:0046943 | |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | 1.35e-04 | 439 | 108 | 10 | GO:0032561 | |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | 1.35e-04 | 439 | 108 | 10 | GO:0019001 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 1.38e-04 | 208 | 108 | 7 | GO:0005342 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 1.42e-04 | 49 | 108 | 4 | GO:0140359 | |
| GeneOntologyMolecularFunction | nucleoside diphosphate phosphatase activity | 1.64e-04 | 20 | 108 | 3 | GO:0017110 | |
| GeneOntologyMolecularFunction | symporter activity | 1.66e-04 | 150 | 108 | 6 | GO:0015293 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ABCC3 GBP6 ABCA4 GBP7 GBP1 GBP2 GBP3 ABCA8 PRUNE1 GBP4 RRAGD GBP5 ABCD4 RAB32 | 1.71e-04 | 839 | 108 | 14 | GO:0016462 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.72e-04 | 151 | 108 | 6 | GO:0015085 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ABCC3 GBP6 ABCA4 GBP7 GBP1 GBP2 GBP3 ABCA8 PRUNE1 GBP4 RRAGD GBP5 ABCD4 RAB32 | 1.73e-04 | 840 | 108 | 14 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ABCC3 GBP6 ABCA4 GBP7 GBP1 GBP2 GBP3 ABCA8 PRUNE1 GBP4 RRAGD GBP5 ABCD4 RAB32 | 1.73e-04 | 840 | 108 | 14 | GO:0016818 |
| GeneOntologyMolecularFunction | GDP binding | 2.42e-04 | 103 | 108 | 5 | GO:0019003 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 2.52e-04 | 23 | 108 | 3 | GO:0015377 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCC3 GBP6 ABCA4 GBP7 GBP1 GBP2 GBP3 ABCA8 GBP4 RRAGD GBP5 ABCD4 RAB32 | 2.82e-04 | 775 | 108 | 13 | GO:0017111 |
| GeneOntologyMolecularFunction | fructose-6-phosphate binding | 2.87e-04 | 5 | 108 | 2 | GO:0070095 | |
| GeneOntologyMolecularFunction | osmolarity-sensing monoatomic cation channel activity | 2.87e-04 | 5 | 108 | 2 | GO:1990760 | |
| GeneOntologyMolecularFunction | G protein activity | 2.93e-04 | 59 | 108 | 4 | GO:0003925 | |
| GeneOntologyMolecularFunction | GTP binding | 3.06e-04 | 397 | 108 | 9 | GO:0005525 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 3.65e-04 | 26 | 108 | 3 | GO:0015296 | |
| GeneOntologyMolecularFunction | osmosensor activity | 4.29e-04 | 6 | 108 | 2 | GO:0005034 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 5.91e-04 | 125 | 108 | 5 | GO:0015108 | |
| GeneOntologyMolecularFunction | phosphofructokinase activity | 5.98e-04 | 7 | 108 | 2 | GO:0008443 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 6.61e-04 | 73 | 108 | 4 | GO:0170055 | |
| GeneOntologyMolecularFunction | calcium channel activity | 6.82e-04 | 129 | 108 | 5 | GO:0005262 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 6.92e-04 | 196 | 108 | 6 | GO:0005319 | |
| GeneOntologyMolecularFunction | dolichyl-phosphate-mannose-protein mannosyltransferase activity | 7.94e-04 | 8 | 108 | 2 | GO:0004169 | |
| GeneOntologyMolecularFunction | spectrin binding | 8.15e-04 | 34 | 108 | 3 | GO:0030507 | |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 8.15e-04 | 34 | 108 | 3 | GO:0042910 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | GABRE ERBB3 CHRNA9 OR4C11 FZD3 TMEM63C OR8H1 CHRM4 OPRM1 P2RX5 OR11A1 ACKR3 SCN7A RORB SMO OR4D5 OR51B2 | 9.31e-04 | 1353 | 108 | 17 | GO:0004888 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 9.86e-04 | 140 | 108 | 5 | GO:0099094 | |
| GeneOntologyMolecularFunction | intracellularly cAMP-activated cation channel activity | 1.27e-03 | 10 | 108 | 2 | GO:0005222 | |
| GeneOntologyMolecularFunction | intracellularly cyclic nucleotide-activated monoatomic cation channel activity | 2.17e-03 | 13 | 108 | 2 | GO:0005221 | |
| GeneOntologyMolecularFunction | cyclic nucleotide-activated monoatomic ion channel activity | 2.17e-03 | 13 | 108 | 2 | GO:0043855 | |
| GeneOntologyMolecularFunction | lipopolysaccharide binding | 2.23e-03 | 48 | 108 | 3 | GO:0001530 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 2.51e-03 | 50 | 108 | 3 | GO:0099095 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 2.54e-03 | 105 | 108 | 4 | GO:0015171 | |
| GeneOntologyMolecularFunction | ABC-type xenobiotic transporter activity | 2.91e-03 | 15 | 108 | 2 | GO:0008559 | |
| GeneOntologyMolecularFunction | icosanoid transmembrane transporter activity | 2.91e-03 | 15 | 108 | 2 | GO:0071714 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 2.91e-03 | 109 | 108 | 4 | GO:0042626 | |
| GeneOntologyMolecularFunction | endopeptidase inhibitor activity | 2.97e-03 | 180 | 108 | 5 | GO:0004866 | |
| GeneOntologyMolecularFunction | Hsp90 protein binding | 3.29e-03 | 55 | 108 | 3 | GO:0051879 | |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | 3.50e-03 | 187 | 108 | 5 | GO:0030414 | |
| GeneOntologyMolecularFunction | sodium:chloride symporter activity | 3.74e-03 | 17 | 108 | 2 | GO:0015378 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 3.99e-03 | 119 | 108 | 4 | GO:0015294 | |
| GeneOntologyMolecularFunction | mechanosensitive monoatomic ion channel activity | 4.19e-03 | 18 | 108 | 2 | GO:0008381 | |
| GeneOntologyMolecularFunction | monoatomic anion:sodium symporter activity | 4.67e-03 | 19 | 108 | 2 | GO:0015373 | |
| GeneOntologyMolecularFunction | endopeptidase regulator activity | 4.75e-03 | 201 | 108 | 5 | GO:0061135 | |
| GeneOntologyMolecularFunction | protein dimerization activity | ERBB3 GBP7 GBP1 XDH GBP2 GBP3 RFPL4AL1 RFPL4A GBP4 RRAGD GBP5 TENM1 MACROH2A2 ANO3 | 5.43e-03 | 1205 | 108 | 14 | GO:0046983 |
| GeneOntologyMolecularFunction | AMP binding | 5.69e-03 | 21 | 108 | 2 | GO:0016208 | |
| GeneOntologyMolecularFunction | carbohydrate kinase activity | 5.69e-03 | 21 | 108 | 2 | GO:0019200 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 6.48e-03 | 70 | 108 | 3 | GO:1901618 | |
| GeneOntologyMolecularFunction | amino acid:sodium symporter activity | 6.81e-03 | 23 | 108 | 2 | GO:0005283 | |
| GeneOntologyBiologicalProcess | sodium ion transport | SLC6A18 SLC4A7 HCN4 HCN1 NEDD4 SLC6A11 SLC8A2 SCN1A SCN2A SCN3A SLC22A5 SCN4A SCN7A SCN8A SCN9A SCN10A AKT2 | 7.54e-14 | 275 | 108 | 17 | GO:0006814 |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 1.76e-13 | 36 | 108 | 9 | GO:0086010 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | SLC6A18 SLC4A7 HCN4 HCN1 NEDD4 SLC6A11 SLC8A2 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A | 2.62e-13 | 208 | 108 | 15 | GO:0035725 |
| GeneOntologyBiologicalProcess | cytolysis in another organism | 1.49e-12 | 9 | 108 | 6 | GO:0051715 | |
| GeneOntologyBiologicalProcess | positive regulation of pyroptotic inflammatory response | 1.49e-12 | 9 | 108 | 6 | GO:0140639 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SLC6A18 GABRE GPM6A CACNA1C ABCC3 SLC4A7 CHRNA9 HCN4 HCN1 PIEZO1 PKD1L1 TMEM63C SLCO1B3 OPRM1 NEDD4 SLC6A11 SLC8A2 PIEZO2 SLC12A4 P2RX5 SCN1A SCN2A SCN3A SLC22A5 SCN4A SCN7A SCN8A SCN9A SCN10A AKT2 ANO3 | 1.81e-12 | 1374 | 108 | 31 | GO:0006811 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SLC6A18 GABRE GPM6A CACNA1C ABCC3 SLC4A7 CHRNA9 HCN4 HCN1 PIEZO1 PKD1L1 TMEM63C OPRM1 NEDD4 SLC6A11 SLC8A2 PIEZO2 SLC12A4 P2RX5 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A ANO3 | 2.23e-12 | 1115 | 108 | 28 | GO:0034220 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SLC6A18 GPM6A CACNA1C SLC4A7 CHRNA9 HCN4 HCN1 PIEZO1 PKD1L1 TMEM63C OPRM1 NEDD4 SLC6A11 SLC8A2 PIEZO2 SLC12A4 P2RX5 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A | 1.31e-11 | 942 | 108 | 25 | GO:0098655 |
| GeneOntologyBiologicalProcess | cytolysis | 1.61e-11 | 12 | 108 | 6 | GO:0019835 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | CACNA1C HCN4 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A | 2.90e-11 | 87 | 108 | 10 | GO:0086001 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SLC6A18 GPM6A CACNA1C SLC4A7 CHRNA9 HCN4 HCN1 PIEZO1 PKD1L1 TMEM63C OPRM1 NEDD4 SLC6A11 SLC8A2 PIEZO2 SLC12A4 P2RX5 SCN1A SCN2A SCN3A SLC22A5 SCN4A SCN7A SCN8A SCN9A SCN10A AKT2 | 3.22e-11 | 1157 | 108 | 27 | GO:0006812 |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 3.39e-11 | 62 | 108 | 9 | GO:0086002 | |
| GeneOntologyBiologicalProcess | membrane depolarization | CACNA1C CHRNA9 HCN4 HCN1 SCN1A SCN2A SCN3A SCN4A SCN8A SCN9A SCN10A | 3.81e-11 | 121 | 108 | 11 | GO:0051899 |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | CACNA1C HCN4 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A | 5.70e-11 | 93 | 108 | 10 | GO:0086003 |
| GeneOntologyBiologicalProcess | regulation of membrane potential | GABRE CACNA1C CHRNA9 HCN4 HCN1 PIEZO1 OPRM1 NEDD4 SLC8A2 PIEZO2 P2RX5 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A | 8.75e-11 | 559 | 108 | 19 | GO:0042391 |
| GeneOntologyBiologicalProcess | metal ion transport | SLC6A18 GPM6A CACNA1C SLC4A7 CHRNA9 HCN4 HCN1 PKD1L1 OPRM1 NEDD4 SLC6A11 SLC8A2 SLC12A4 P2RX5 SCN1A SCN2A SCN3A SLC22A5 SCN4A SCN7A SCN8A SCN9A SCN10A AKT2 | 2.84e-10 | 1000 | 108 | 24 | GO:0030001 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SLC6A18 GABRE GPM6A CACNA1C SLC4A7 CHRNA9 HCN4 HCN1 PKD1L1 OPRM1 NEDD4 SLC6A11 SLC8A2 SLC12A4 P2RX5 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A ANO3 | 3.98e-10 | 1017 | 108 | 24 | GO:0098660 |
| GeneOntologyBiologicalProcess | action potential | CACNA1C HCN4 HCN1 SLC8A2 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A | 6.49e-10 | 201 | 108 | 12 | GO:0001508 |
| GeneOntologyBiologicalProcess | adhesion of symbiont to host | 6.54e-10 | 20 | 108 | 6 | GO:0044406 | |
| GeneOntologyBiologicalProcess | positive regulation of AIM2 inflammasome complex assembly | 7.11e-10 | 4 | 108 | 4 | GO:0140973 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | CACNA1C HCN4 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A | 1.27e-09 | 127 | 108 | 10 | GO:0070252 |
| GeneOntologyBiologicalProcess | neuronal action potential | 1.33e-09 | 63 | 108 | 8 | GO:0019228 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SLC6A18 GPM6A CACNA1C SLC4A7 CHRNA9 HCN4 HCN1 PKD1L1 OPRM1 NEDD4 SLC6A11 SLC8A2 SLC12A4 P2RX5 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A | 1.99e-09 | 922 | 108 | 22 | GO:0098662 |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus | 5.48e-09 | 75 | 108 | 8 | GO:0050982 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 7.40e-09 | 112 | 108 | 9 | GO:0019226 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | CACNA1C HCN4 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A | 7.80e-09 | 153 | 108 | 10 | GO:0030048 |
| GeneOntologyBiologicalProcess | regulation of AIM2 inflammasome complex assembly | 1.06e-08 | 6 | 108 | 4 | GO:0140971 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | CACNA1C HCN4 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A | 1.81e-08 | 167 | 108 | 10 | GO:0060048 |
| GeneOntologyBiologicalProcess | AIM2 inflammasome complex assembly | 4.90e-08 | 8 | 108 | 4 | GO:0140970 | |
| GeneOntologyBiologicalProcess | defense response to protozoan | 5.08e-08 | 39 | 108 | 6 | GO:0042832 | |
| GeneOntologyBiologicalProcess | cellular response to interferon-beta | 6.94e-08 | 41 | 108 | 6 | GO:0035458 | |
| GeneOntologyBiologicalProcess | response to protozoan | 8.06e-08 | 42 | 108 | 6 | GO:0001562 | |
| GeneOntologyBiologicalProcess | pyroptotic inflammatory response | 8.06e-08 | 42 | 108 | 6 | GO:0070269 | |
| GeneOntologyBiologicalProcess | response to interferon-beta | 1.84e-07 | 48 | 108 | 6 | GO:0035456 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | CACNA1C HCN4 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A | 2.13e-07 | 217 | 108 | 10 | GO:0006941 |
| GeneOntologyBiologicalProcess | detection of external stimulus | 3.20e-07 | 173 | 108 | 9 | GO:0009581 | |
| GeneOntologyBiologicalProcess | detection of abiotic stimulus | 3.53e-07 | 175 | 108 | 9 | GO:0009582 | |
| GeneOntologyBiologicalProcess | heart contraction | CACNA1C HCN4 SLC8A2 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A | 4.74e-07 | 298 | 108 | 11 | GO:0060047 |
| GeneOntologyBiologicalProcess | heart process | CACNA1C HCN4 SLC8A2 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A | 6.78e-07 | 309 | 108 | 11 | GO:0003015 |
| GeneOntologyBiologicalProcess | response to type II interferon | 7.73e-07 | 141 | 108 | 8 | GO:0034341 | |
| GeneOntologyBiologicalProcess | cellular response to type II interferon | 2.30e-06 | 114 | 108 | 7 | GO:0071346 | |
| GeneOntologyBiologicalProcess | detection of stimulus | ABCA4 CHRNA9 OR4C11 PIEZO1 PKD1L1 OR8H1 PIEZO2 OR11A1 SCN1A SCN9A SCN10A SMO OR4D5 ANO3 OR51B2 | 5.36e-06 | 722 | 108 | 15 | GO:0051606 |
| GeneOntologyBiologicalProcess | positive regulation of inflammasome-mediated signaling pathway | 9.72e-06 | 26 | 108 | 4 | GO:0141087 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus involved in sensory perception | 1.21e-05 | 57 | 108 | 5 | GO:0050974 | |
| GeneOntologyBiologicalProcess | biological process involved in interaction with host | 2.69e-05 | 228 | 108 | 8 | GO:0051701 | |
| GeneOntologyBiologicalProcess | cellular response to lipopolysaccharide | 4.52e-05 | 318 | 108 | 9 | GO:0071222 | |
| GeneOntologyBiologicalProcess | response to mechanical stimulus | 4.74e-05 | 247 | 108 | 8 | GO:0009612 | |
| GeneOntologyBiologicalProcess | muscle contraction | CACNA1C HCN4 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A | 4.81e-05 | 400 | 108 | 10 | GO:0006936 |
| GeneOntologyBiologicalProcess | killing of cells of another organism | 6.05e-05 | 129 | 108 | 6 | GO:0031640 | |
| GeneOntologyBiologicalProcess | disruption of cell in another organism | 6.05e-05 | 129 | 108 | 6 | GO:0141061 | |
| GeneOntologyBiologicalProcess | cellular response to molecule of bacterial origin | 6.29e-05 | 332 | 108 | 9 | GO:0071219 | |
| GeneOntologyBiologicalProcess | regulation of action potential | 6.70e-05 | 81 | 108 | 5 | GO:0098900 | |
| GeneOntologyBiologicalProcess | disruption of anatomical structure in another organism | 6.88e-05 | 132 | 108 | 6 | GO:0141060 | |
| GeneOntologyBiologicalProcess | response to abiotic stimulus | CUL4B CACNA1C ABCA4 CHRNA9 FZD3 TM9SF4 PIEZO1 PKD1L1 NEDD4 PIEZO2 P2RX5 SCN1A SCN2A SCN7A SCN9A SCN10A AKT2 ANO3 FBXW7 | 7.69e-05 | 1361 | 108 | 19 | GO:0009628 |
| GeneOntologyBiologicalProcess | regulation of inflammasome-mediated signaling pathway | 1.16e-04 | 48 | 108 | 4 | GO:0141085 | |
| GeneOntologyBiologicalProcess | circulatory system process | CACNA1C ABCC3 HCN4 SLC8A2 SCN1A SCN2A SCN3A SLC22A5 SCN4A SCN7A SCN8A SCN9A SCN10A | 1.19e-04 | 733 | 108 | 13 | GO:0003013 |
| GeneOntologyBiologicalProcess | cellular response to biotic stimulus | 1.27e-04 | 364 | 108 | 9 | GO:0071216 | |
| GeneOntologyBiologicalProcess | defense response to Gram-positive bacterium | 1.39e-04 | 150 | 108 | 6 | GO:0050830 | |
| GeneOntologyBiologicalProcess | muscle system process | CACNA1C HCN4 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A MYMK | 1.40e-04 | 547 | 108 | 11 | GO:0003012 |
| GeneOntologyBiologicalProcess | sensory perception | ABCA4 SLC4A7 CHRNA9 OR4C11 OR8H1 OMP OPRM1 PIEZO2 OR11A1 SCN1A SCN8A SCN9A SCN10A RORB OR4D5 OR51B2 | 1.42e-04 | 1072 | 108 | 16 | GO:0007600 |
| GeneOntologyBiologicalProcess | cellular response to lipid | GBP6 AICDA GBP7 GBP1 GBP2 GBP3 NCL ADCY1 NEDD4 GBP4 GBP5 RORB SMO | 1.46e-04 | 748 | 108 | 13 | GO:0071396 |
| GeneOntologyBiologicalProcess | protein targeting | 1.52e-04 | 373 | 108 | 9 | GO:0006605 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 1.55e-04 | 153 | 108 | 6 | GO:0098656 | |
| GeneOntologyBiologicalProcess | inflammasome-mediated signaling pathway | 1.71e-04 | 53 | 108 | 4 | GO:0141084 | |
| GeneOntologyBiologicalProcess | regulation of cellular localization | CACNA1C GBP6 TM9SF4 GBP1 NBEA PFKL OPRM1 RFPL4AL1 NEDD4 ARHGDIG RFPL4A LMAN1 P2RX5 TENM1 AKT2 SMO FBXW7 | 1.82e-04 | 1212 | 108 | 17 | GO:0060341 |
| GeneOntologyBiologicalProcess | import across plasma membrane | 2.10e-04 | 230 | 108 | 7 | GO:0098739 | |
| GeneOntologyBiologicalProcess | sensory perception of mechanical stimulus | 2.59e-04 | 238 | 108 | 7 | GO:0050954 | |
| GeneOntologyBiologicalProcess | nerve development | 2.72e-04 | 109 | 108 | 5 | GO:0021675 | |
| GeneOntologyBiologicalProcess | regulation of membrane depolarization | 2.95e-04 | 61 | 108 | 4 | GO:0003254 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 3.72e-04 | 180 | 108 | 6 | GO:0060078 | |
| GeneOntologyBiologicalProcess | organic anion transport | SLC25A24 ABCC3 SLC4A7 SLC43A1 SLCO1B3 SLC6A11 SLC16A14 ABCD4 SERINC3 AKT2 | 3.75e-04 | 515 | 108 | 10 | GO:0015711 |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 4.07e-04 | 183 | 108 | 6 | GO:0006820 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular signal transduction | ERBB3 GBP1 XDH GBP2 GBP3 TMEM101 OPRM1 RFPL4AL1 NEDD4 RFPL4A RRAGD P2RX5 GBP5 ACKR3 TENM1 SERINC3 FBXW7 | 4.09e-04 | 1299 | 108 | 17 | GO:1902533 |
| GeneOntologyBiologicalProcess | defense response to virus | 4.40e-04 | 342 | 108 | 8 | GO:0051607 | |
| GeneOntologyBiologicalProcess | cellular response to oxygen-containing compound | GBP6 AICDA GBP7 HCN4 HCN1 GBP1 GBP2 GBP3 NCL ADCY1 CHRM4 OPRM1 GBP4 RRAGD GBP5 RORB AKT2 SMO | 5.11e-04 | 1450 | 108 | 18 | GO:1901701 |
| GeneOntologyBiologicalProcess | biological process involved in symbiotic interaction | 5.22e-04 | 351 | 108 | 8 | GO:0044403 | |
| GeneOntologyBiologicalProcess | regulation of protein localization | CACNA1C GBP6 TM9SF4 GBP1 NBEA PFKL OPRM1 RFPL4AL1 ARHGDIG RFPL4A LMAN1 TENM1 AKT2 SMO FBXW7 | 5.36e-04 | 1087 | 108 | 15 | GO:0032880 |
| GeneOntologyBiologicalProcess | positive regulation of inflammatory response | 5.39e-04 | 193 | 108 | 6 | GO:0050729 | |
| GeneOntologyBiologicalProcess | blood circulation | CACNA1C HCN4 SLC8A2 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A | 5.91e-04 | 648 | 108 | 11 | GO:0008015 |
| GeneOntologyBiologicalProcess | behavioral response to pain | 6.20e-04 | 32 | 108 | 3 | GO:0048266 | |
| GeneOntologyBiologicalProcess | detection of temperature stimulus | 6.79e-04 | 33 | 108 | 3 | GO:0016048 | |
| GeneOntologyBiologicalProcess | cell-cell signaling involved in cardiac conduction | 7.42e-04 | 34 | 108 | 3 | GO:0086019 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway | 7.45e-04 | 8 | 108 | 2 | GO:0007197 | |
| GeneOntologyBiologicalProcess | response to lipopolysaccharide | 7.47e-04 | 464 | 108 | 9 | GO:0032496 | |
| GeneOntologyBiologicalProcess | cellular response to abiotic stimulus | 7.49e-04 | 371 | 108 | 8 | GO:0071214 | |
| GeneOntologyBiologicalProcess | cellular response to environmental stimulus | 7.49e-04 | 371 | 108 | 8 | GO:0104004 | |
| GeneOntologyBiologicalProcess | behavior | CACNA1C SLC4A7 HCN1 ADCY1 OPRM1 SLC8A2 SCN1A SCN2A SCN3A SLC22A5 SCN8A SCN9A SCN10A | 7.75e-04 | 891 | 108 | 13 | GO:0007610 |
| GeneOntologyBiologicalProcess | positive regulation of pattern recognition receptor signaling pathway | 7.90e-04 | 79 | 108 | 4 | GO:0062208 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid transport | 9.02e-04 | 213 | 108 | 6 | GO:0015718 | |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 9.10e-04 | 142 | 108 | 5 | GO:0099587 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 9.10e-04 | 142 | 108 | 5 | GO:0098659 | |
| GeneOntologyBiologicalProcess | fructose 1,6-bisphosphate metabolic process | 9.55e-04 | 9 | 108 | 2 | GO:0030388 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | CHRNA9 OR4C11 OR8H1 PIEZO2 OR11A1 SCN1A SCN9A SCN10A OR4D5 OR51B2 | 9.63e-04 | 582 | 108 | 10 | GO:0050906 |
| GeneOntologyBiologicalProcess | response to bacterium | GPM6A GBP6 AICDA GBP7 GBP1 GBP2 GBP3 NCL GBP4 GBP5 SLC22A5 SCN7A FKBP5 | 9.99e-04 | 916 | 108 | 13 | GO:0009617 |
| GeneOntologyBiologicalProcess | response to molecule of bacterial origin | 1.11e-03 | 491 | 108 | 9 | GO:0002237 | |
| GeneOntologyBiologicalProcess | positive regulation of cytosolic calcium ion concentration | 1.17e-03 | 224 | 108 | 6 | GO:0007204 | |
| GeneOntologyBiologicalProcess | negative regulation of action potential | 1.19e-03 | 10 | 108 | 2 | GO:0045759 | |
| GeneOntologyBiologicalProcess | positive regulation of protein-containing complex assembly | 1.25e-03 | 227 | 108 | 6 | GO:0031334 | |
| GeneOntologyBiologicalProcess | defense response to bacterium | 1.31e-03 | 405 | 108 | 8 | GO:0042742 | |
| GeneOntologyBiologicalProcess | calcium ion transport into cytosol | 1.38e-03 | 42 | 108 | 3 | GO:0060402 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 9.12e-15 | 17 | 108 | 8 | GO:0001518 | |
| GeneOntologyCellularComponent | host cell part | 1.65e-14 | 6 | 108 | 6 | GO:0033643 | |
| GeneOntologyCellularComponent | host intracellular part | 1.65e-14 | 6 | 108 | 6 | GO:0033646 | |
| GeneOntologyCellularComponent | host cell cytoplasm part | 1.65e-14 | 6 | 108 | 6 | GO:0033655 | |
| GeneOntologyCellularComponent | symbiont-containing vacuole | 1.65e-14 | 6 | 108 | 6 | GO:0020003 | |
| GeneOntologyCellularComponent | symbiont-containing vacuole membrane | 1.65e-14 | 6 | 108 | 6 | GO:0020005 | |
| GeneOntologyCellularComponent | host intracellular region | 1.65e-14 | 6 | 108 | 6 | GO:0043656 | |
| GeneOntologyCellularComponent | host cell cytoplasm | 1.65e-14 | 6 | 108 | 6 | GO:0030430 | |
| GeneOntologyCellularComponent | sodium channel complex | 1.53e-12 | 29 | 108 | 8 | GO:0034706 | |
| GeneOntologyCellularComponent | host cellular component | 7.96e-11 | 15 | 108 | 6 | GO:0018995 | |
| GeneOntologyCellularComponent | synaptic membrane | GABRE GPM6A CACNA1C ERBB3 LRFN1 CHRNA9 FZD3 HCN1 NBEA ADCY1 CHRM4 OPRM1 SLC6A11 SLC8A2 SCN1A SCN2A SCN8A SCN10A | 1.09e-09 | 583 | 108 | 18 | GO:0097060 |
| GeneOntologyCellularComponent | cation channel complex | CACNA1C HCN4 HCN1 PKD1L1 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A | 3.31e-09 | 235 | 108 | 12 | GO:0034703 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | GABRE CACNA1C CHRNA9 HCN4 HCN1 PKD1L1 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A | 9.44e-09 | 378 | 108 | 14 | GO:0034702 |
| GeneOntologyCellularComponent | presynaptic membrane | GPM6A CACNA1C LRFN1 FZD3 HCN1 CHRM4 OPRM1 SLC6A11 SCN1A SCN2A SCN8A SCN10A | 2.08e-08 | 277 | 108 | 12 | GO:0042734 |
| GeneOntologyCellularComponent | symbiont cell surface | 4.64e-08 | 8 | 108 | 4 | GO:0106139 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | GABRE CACNA1C CHRNA9 HCN4 HCN1 PKD1L1 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A ABCD4 | 7.97e-08 | 523 | 108 | 15 | GO:1902495 |
| GeneOntologyCellularComponent | other organism part | 8.32e-08 | 9 | 108 | 4 | GO:0044217 | |
| GeneOntologyCellularComponent | transporter complex | GABRE CACNA1C CHRNA9 HCN4 HCN1 PKD1L1 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A ABCD4 | 1.53e-07 | 550 | 108 | 15 | GO:1990351 |
| GeneOntologyCellularComponent | postsynaptic membrane | GABRE CACNA1C ERBB3 LRFN1 CHRNA9 HCN1 NBEA ADCY1 CHRM4 OPRM1 SLC6A11 SLC8A2 SCN8A | 1.74e-07 | 405 | 108 | 13 | GO:0045211 |
| GeneOntologyCellularComponent | postsynapse | GABRE GPM6A CACNA1C ERBB3 LRFN1 CHRNA9 HCN1 NBEA ADCY1 CHRM4 OPRM1 NEDD4 SLC6A11 DIP2A SLC8A2 P2RX5 RBMX SCN8A RPL9 | 1.05e-06 | 1018 | 108 | 19 | GO:0098794 |
| GeneOntologyCellularComponent | axon | GPM6A CACNA1C HCN4 FZD3 HCN1 CHRM4 OMP OPRM1 SLC8A2 SCN1A SCN2A SCN3A SCN4A SCN8A SCN9A SCN10A SMO | 3.12e-06 | 891 | 108 | 17 | GO:0030424 |
| GeneOntologyCellularComponent | presynapse | GPM6A CACNA1C LRFN1 HCN4 FZD3 HCN1 ADCY1 CHRM4 OPRM1 SLC6A11 SLC8A2 SCN1A SCN2A SCN8A SCN10A RPL9 | 1.25e-05 | 886 | 108 | 16 | GO:0098793 |
| GeneOntologyCellularComponent | cell projection membrane | SLC6A18 GABRE HCN1 PIEZO1 PKD1L1 OPRM1 MTMR6 SLC22A5 AKT2 SMO TCTN2 | 1.45e-05 | 431 | 108 | 11 | GO:0031253 |
| GeneOntologyCellularComponent | basolateral plasma membrane | 4.28e-05 | 320 | 108 | 9 | GO:0016323 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | CACNA1C ERBB3 CHRNA9 HCN4 HCN1 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A ABCD4 | 5.25e-05 | 785 | 108 | 14 | GO:0098797 |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 5.25e-05 | 78 | 108 | 5 | GO:0048787 | |
| GeneOntologyCellularComponent | 6-phosphofructokinase complex | 7.91e-05 | 3 | 108 | 2 | GO:0005945 | |
| GeneOntologyCellularComponent | basal plasma membrane | 9.28e-05 | 354 | 108 | 9 | GO:0009925 | |
| GeneOntologyCellularComponent | node of Ranvier | 1.43e-04 | 20 | 108 | 3 | GO:0033268 | |
| GeneOntologyCellularComponent | basal part of cell | 1.52e-04 | 378 | 108 | 9 | GO:0045178 | |
| GeneOntologyCellularComponent | HCN channel complex | 1.58e-04 | 4 | 108 | 2 | GO:0098855 | |
| GeneOntologyCellularComponent | glutamatergic synapse | GPM6A CACNA1C FZD3 HCN1 NBEA ADCY1 CHRM4 NEDD4 DIP2A RBMX SCN2A SCN8A SCN10A | 3.03e-04 | 817 | 108 | 13 | GO:0098978 |
| GeneOntologyCellularComponent | sarcoplasm | 3.15e-04 | 114 | 108 | 5 | GO:0016528 | |
| GeneOntologyCellularComponent | neuronal cell body | GPM6A CACNA1C HCN4 FZD3 HCN1 CHRM4 OMP OPRM1 SLC8A2 SCN1A SCN3A SCN8A SMO | 3.73e-04 | 835 | 108 | 13 | GO:0043025 |
| GeneOntologyCellularComponent | axon initial segment | 4.44e-04 | 29 | 108 | 3 | GO:0043194 | |
| GeneOntologyCellularComponent | sarcolemma | 4.63e-04 | 190 | 108 | 6 | GO:0042383 | |
| GeneOntologyCellularComponent | dendrite | GABRE GPM6A CACNA1C HCN4 FZD3 HCN1 CHRM4 OPRM1 NEDD4 DIP2A SLC8A2 SCN8A SMO | 4.82e-04 | 858 | 108 | 13 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | GABRE GPM6A CACNA1C HCN4 FZD3 HCN1 CHRM4 OPRM1 NEDD4 DIP2A SLC8A2 SCN8A SMO | 4.92e-04 | 860 | 108 | 13 | GO:0097447 |
| GeneOntologyCellularComponent | somatodendritic compartment | GABRE GPM6A CACNA1C HCN4 FZD3 HCN1 CHRM4 OMP OPRM1 NEDD4 DIP2A SLC8A2 SCN1A SCN3A SCN8A SMO | 5.59e-04 | 1228 | 108 | 16 | GO:0036477 |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 6.22e-04 | 201 | 108 | 6 | GO:0099634 | |
| GeneOntologyCellularComponent | T-tubule | 7.52e-04 | 79 | 108 | 4 | GO:0030315 | |
| GeneOntologyCellularComponent | leading edge membrane | 7.82e-04 | 210 | 108 | 6 | GO:0031256 | |
| GeneOntologyCellularComponent | presynaptic active zone | 8.31e-04 | 141 | 108 | 5 | GO:0048786 | |
| GeneOntologyCellularComponent | cell body | GPM6A CACNA1C HCN4 FZD3 HCN1 CHRM4 OMP OPRM1 SLC8A2 SCN1A SCN3A SCN8A SMO | 1.01e-03 | 929 | 108 | 13 | GO:0044297 |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 1.13e-03 | 88 | 108 | 4 | GO:0016529 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 1.34e-03 | 157 | 108 | 5 | GO:0098839 | |
| GeneOntologyCellularComponent | membrane protein complex | GABRE CACNA1C ERBB3 CHRNA9 HCN4 HCN1 PKD1L1 STT3B SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A ABCD4 | 1.71e-03 | 1498 | 108 | 17 | GO:0098796 |
| GeneOntologyCellularComponent | dendrite membrane | 3.05e-03 | 56 | 108 | 3 | GO:0032590 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | GBP7 HCN4 GBP1 GBP2 GBP3 NEDD4 MTMR6 GBP4 GBP5 TENM1 SERINC3 FBXW7 | 3.20e-03 | 934 | 108 | 12 | GO:0048471 |
| GeneOntologyCellularComponent | postsynaptic specialization | 4.59e-03 | 503 | 108 | 8 | GO:0099572 | |
| GeneOntologyCellularComponent | endoplasmic reticulum-Golgi intermediate compartment | 6.19e-03 | 141 | 108 | 4 | GO:0005793 | |
| HumanPheno | Generalized cerebral atrophy/hypoplasia | 4.66e-06 | 13 | 48 | 4 | HP:0007058 | |
| HumanPheno | Cortical dysplasia | 1.15e-05 | 56 | 48 | 6 | HP:0002539 | |
| HumanPheno | Complex febrile seizure | 1.16e-05 | 16 | 48 | 4 | HP:0011172 | |
| HumanPheno | Atypical absence status epilepticus | 1.51e-05 | 17 | 48 | 4 | HP:0011151 | |
| HumanPheno | Generalized non-convulsive status epilepticus without coma | 1.93e-05 | 18 | 48 | 4 | HP:0032860 | |
| HumanPheno | Non-convulsive status epilepticus without coma | 3.01e-05 | 20 | 48 | 4 | HP:0032671 | |
| HumanPheno | Talipes valgus | 3.69e-05 | 21 | 48 | 4 | HP:0004684 | |
| HumanPheno | Photosensitive myoclonic seizure | 4.26e-05 | 8 | 48 | 3 | HP:0001327 | |
| HumanPheno | Cyanotic episode | 4.26e-05 | 8 | 48 | 3 | HP:0200048 | |
| HumanPheno | Tibial torsion | 5.39e-05 | 23 | 48 | 4 | HP:0100694 | |
| HumanPheno | Focal hemiclonic seizure | 7.59e-05 | 25 | 48 | 4 | HP:0006813 | |
| HumanPheno | Clonic seizure | 9.66e-05 | 81 | 48 | 6 | HP:0020221 | |
| HumanPheno | Limited knee extension | 1.04e-04 | 27 | 48 | 4 | HP:0003066 | |
| HumanPheno | Status epilepticus without prominent motor symptoms | 1.04e-04 | 27 | 48 | 4 | HP:0031475 | |
| HumanPheno | Simple febrile seizure | 1.04e-04 | 27 | 48 | 4 | HP:0011171 | |
| HumanPheno | Limited neck range of motion | 1.23e-04 | 11 | 48 | 3 | HP:0000466 | |
| HumanPheno | Poor motor coordination | 1.27e-04 | 85 | 48 | 6 | HP:0002275 | |
| HumanPheno | Pes valgus | 1.60e-04 | 56 | 48 | 5 | HP:0008081 | |
| HumanPheno | Epilepsia partialis continua | 1.63e-04 | 12 | 48 | 3 | HP:0012847 | |
| HumanPheno | Focal automatism seizure | 1.63e-04 | 12 | 48 | 3 | HP:0032898 | |
| HumanPheno | Obsessive-compulsive trait | 2.32e-04 | 33 | 48 | 4 | HP:0008770 | |
| HumanPheno | Generalized clonic seizure | 2.62e-04 | 34 | 48 | 4 | HP:0011169 | |
| HumanPheno | Calcaneovalgus deformity | 2.62e-04 | 34 | 48 | 4 | HP:0001848 | |
| HumanPheno | Deformed tarsal bones | 2.93e-04 | 35 | 48 | 4 | HP:0008119 | |
| HumanPheno | Limitation of knee mobility | 2.93e-04 | 35 | 48 | 4 | HP:0010501 | |
| HumanPheno | Aortopulmonary collateral arteries | 3.30e-04 | 15 | 48 | 3 | HP:0031834 | |
| HumanPheno | Facial tics | 3.30e-04 | 15 | 48 | 3 | HP:0011468 | |
| HumanPheno | Photosensitive tonic-clonic seizure | 3.30e-04 | 15 | 48 | 3 | HP:0007207 | |
| HumanPheno | Dysgenesis of the hippocampus | 4.04e-04 | 16 | 48 | 3 | HP:0025101 | |
| HumanPheno | Poor fine motor coordination | 4.29e-04 | 69 | 48 | 5 | HP:0007010 | |
| HumanPheno | Non-motor seizure | 4.32e-04 | 197 | 48 | 8 | HP:0033259 | |
| HumanPheno | Aplasia/Hypoplasia of the tongue | 4.48e-04 | 39 | 48 | 4 | HP:0010295 | |
| HumanPheno | Focal motor status epilepticus | 4.87e-04 | 17 | 48 | 3 | HP:0032663 | |
| HumanPheno | Focal non-motor seizure | 4.95e-04 | 40 | 48 | 4 | HP:0032679 | |
| HumanPheno | Visually-induced seizure | 5.80e-04 | 18 | 48 | 3 | HP:0020216 | |
| HumanPheno | Focal emotional seizure | 5.80e-04 | 18 | 48 | 3 | HP:0025613 | |
| HumanPheno | Microglossia | 5.80e-04 | 18 | 48 | 3 | HP:0000171 | |
| HumanPheno | Focal clonic seizure | 5.97e-04 | 42 | 48 | 4 | HP:0002266 | |
| HumanPheno | Myoclonic seizure | 6.28e-04 | 262 | 48 | 9 | HP:0032794 | |
| HumanPheno | Motor seizure | CACNA1C HCN4 HCN1 NBEA PRUNE1 SCN1A SCN2A SCN3A SLC22A5 SCN8A SCN9A RORB AKT2 SMO | 7.04e-04 | 586 | 48 | 14 | HP:0020219 |
| HumanPheno | Gastroesophageal reflux | SLC25A24 CACNA1C HCN1 PIEZO1 PRUNE1 PIEZO2 SCN3A SCN8A SCN9A ABCD4 MYMK MED12 FBXW7 | 7.11e-04 | 517 | 48 | 13 | HP:0002020 |
| HumanPheno | Atypical absence seizure | 8.47e-04 | 46 | 48 | 4 | HP:0007270 | |
| HumanPheno | Neonatal electro-clinical non-motor seizure | 8.54e-04 | 5 | 48 | 2 | HP:0032812 | |
| HumanPheno | Neonatal seizure with electrographic correlate | 8.54e-04 | 5 | 48 | 2 | HP:0032808 | |
| HumanPheno | Neonatal electro-clinical seizure | 8.54e-04 | 5 | 48 | 2 | HP:0032809 | |
| HumanPheno | Neonatal electro-clinical seizure with behavior arrest | 8.54e-04 | 5 | 48 | 2 | HP:0032823 | |
| HumanPheno | Focal head nodding automatism seizure | 8.54e-04 | 5 | 48 | 2 | HP:0032906 | |
| HumanPheno | Allodynia | 8.54e-04 | 5 | 48 | 2 | HP:0012533 | |
| MousePheno | abnormal action potential | 1.69e-06 | 133 | 87 | 8 | MP:0005402 | |
| MousePheno | increased heart rate variability | 5.22e-06 | 41 | 87 | 5 | MP:0003928 | |
| MousePheno | abnormal RR interval | 6.71e-06 | 160 | 87 | 8 | MP:0010504 | |
| MousePheno | decreased heart rate | 1.16e-05 | 288 | 87 | 10 | MP:0005333 | |
| MousePheno | abnormal heart rate | GABRE CACNA1C SLC4A7 HCN4 HCN1 GBP1 GBP2 GBP3 CHRM4 SCN1A SCN10A SMO | 1.90e-05 | 445 | 87 | 12 | MP:0001629 |
| MousePheno | increased susceptibility to parasitic infection induced morbidity/mortality | 3.71e-05 | 11 | 87 | 3 | MP:0010750 | |
| MousePheno | abnormal behavioral response to anesthetic | 4.92e-05 | 12 | 87 | 3 | MP:0009777 | |
| MousePheno | abnormal heartbeat | GABRE CACNA1C SLC4A7 HCN4 HCN1 GBP1 GBP2 GBP3 CHRM4 SCN1A SCN10A SMO | 6.05e-05 | 501 | 87 | 12 | MP:0004085 |
| MousePheno | impaired ability to fire action potentials | 6.37e-05 | 13 | 87 | 3 | MP:0002578 | |
| MousePheno | abnormal touch/ nociception | CACNA1C ABCC3 ERBB3 HCN1 NBEA ADCY1 OPRM1 SCN9A SCN10A ABCD4 | 1.11e-04 | 376 | 87 | 10 | MP:0001968 |
| MousePheno | abnormal sinus arrhythmia | 1.23e-04 | 78 | 87 | 5 | MP:0004122 | |
| MousePheno | abnormal nervous system electrophysiology | 2.03e-04 | 329 | 87 | 9 | MP:0002272 | |
| MousePheno | prolonged RR interval | 2.26e-04 | 139 | 87 | 6 | MP:0010506 | |
| MousePheno | impaired behavioral response to anesthetic | 3.78e-04 | 5 | 87 | 2 | MP:0009778 | |
| MousePheno | enhanced behavioral response to anesthetic | 3.78e-04 | 5 | 87 | 2 | MP:0009779 | |
| Domain | Na_channel_asu | 4.28e-17 | 10 | 108 | 8 | IPR001696 | |
| Domain | Na_trans_assoc | 4.28e-17 | 10 | 108 | 8 | IPR010526 | |
| Domain | Na_trans_assoc | 4.28e-17 | 10 | 108 | 8 | PF06512 | |
| Domain | GBP_C | 2.10e-14 | 10 | 108 | 7 | PF02841 | |
| Domain | G_GB1_RHD3_dom | 5.75e-14 | 11 | 108 | 7 | IPR030386 | |
| Domain | Guanylate-bd_C | 5.75e-14 | 11 | 108 | 7 | IPR003191 | |
| Domain | GBP | 5.75e-14 | 11 | 108 | 7 | PF02263 | |
| Domain | Guanylate-bd_N | 5.75e-14 | 11 | 108 | 7 | IPR015894 | |
| Domain | G_GB1_RHD3 | 5.75e-14 | 11 | 108 | 7 | PS51715 | |
| Domain | Na_trans_cytopl | 3.52e-11 | 6 | 108 | 5 | PF11933 | |
| Domain | Na_trans_cytopl | 3.52e-11 | 6 | 108 | 5 | IPR024583 | |
| Domain | Channel_four-helix_dom | 3.68e-11 | 57 | 108 | 9 | IPR027359 | |
| Domain | - | 3.68e-11 | 57 | 108 | 9 | 1.20.120.350 | |
| Domain | Ion_trans_dom | CACNA1C HCN4 HCN1 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A | 5.63e-11 | 114 | 108 | 11 | IPR005821 |
| Domain | Ion_trans | CACNA1C HCN4 HCN1 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A | 5.63e-11 | 114 | 108 | 11 | PF00520 |
| Domain | IQ_motif_EF-hand-BS | 5.03e-08 | 90 | 108 | 8 | IPR000048 | |
| Domain | IQ | 4.35e-07 | 81 | 108 | 7 | SM00015 | |
| Domain | IQ | 1.12e-06 | 93 | 108 | 7 | PS50096 | |
| Domain | IQ | 3.43e-06 | 71 | 108 | 6 | PF00612 | |
| Domain | PIEZO | 3.31e-05 | 2 | 108 | 2 | PF15917 | |
| Domain | Piezo_RRas-bd_dom | 3.31e-05 | 2 | 108 | 2 | IPR031334 | |
| Domain | Piezo | 3.31e-05 | 2 | 108 | 2 | IPR027272 | |
| Domain | Piezo_RRas_bdg | 3.31e-05 | 2 | 108 | 2 | PF12166 | |
| Domain | Piezo_dom | 3.31e-05 | 2 | 108 | 2 | IPR031805 | |
| Domain | PHOSPHOFRUCTOKINASE | 9.90e-05 | 3 | 108 | 2 | PS00433 | |
| Domain | 6-Pfructokinase_euk | 9.90e-05 | 3 | 108 | 2 | IPR009161 | |
| Domain | Phosphofructokinase_CS | 9.90e-05 | 3 | 108 | 2 | IPR015912 | |
| Domain | PFK | 9.90e-05 | 3 | 108 | 2 | PF00365 | |
| Domain | ATP_PFK | 9.90e-05 | 3 | 108 | 2 | IPR022953 | |
| Domain | Phosphofructokinase_dom | 9.90e-05 | 3 | 108 | 2 | IPR000023 | |
| Domain | ABC_tran | 1.69e-04 | 48 | 108 | 4 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 1.69e-04 | 48 | 108 | 4 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 1.83e-04 | 49 | 108 | 4 | PS00211 | |
| Domain | Ion_trans_N | 1.97e-04 | 4 | 108 | 2 | PF08412 | |
| Domain | Ion_trans_N | 1.97e-04 | 4 | 108 | 2 | IPR013621 | |
| Domain | ABC_transporter-like | 1.98e-04 | 50 | 108 | 4 | IPR003439 | |
| Domain | RDM | 3.28e-04 | 5 | 108 | 2 | PF11002 | |
| Domain | RDM_domain_RFPL | 3.28e-04 | 5 | 108 | 2 | IPR022723 | |
| Domain | DMAP_binding | 3.28e-04 | 5 | 108 | 2 | PF06464 | |
| Domain | - | ABCC3 GBP6 ABCA4 GBP7 GBP1 GBP2 GBP3 ABCA8 GBP4 RRAGD GBP5 ABCD4 RAB32 | 3.70e-04 | 746 | 108 | 13 | 3.40.50.300 |
| Domain | DMAP1-bd | 4.89e-04 | 6 | 108 | 2 | IPR010506 | |
| Domain | DMAP_binding | 4.89e-04 | 6 | 108 | 2 | SM01137 | |
| Domain | P-loop_NTPase | ABCC3 GBP6 ABCA4 GBP7 GBP1 GBP2 GBP3 ABCA8 GBP4 RRAGD GBP5 ABCD4 RAB32 | 1.22e-03 | 848 | 108 | 13 | IPR027417 |
| Domain | EF-hand-dom_pair | 1.40e-03 | 287 | 108 | 7 | IPR011992 | |
| Domain | Frizzled | 1.76e-03 | 11 | 108 | 2 | IPR000539 | |
| Domain | Frizzled | 1.76e-03 | 11 | 108 | 2 | PF01534 | |
| Domain | Frizzled | 1.76e-03 | 11 | 108 | 2 | SM01330 | |
| Domain | ABC_transporter_CS | 1.83e-03 | 42 | 108 | 3 | IPR017871 | |
| Domain | ABC_A | 2.11e-03 | 12 | 108 | 2 | IPR026082 | |
| Domain | K_chnl_volt-dep_EAG/ELK/ERG | 2.88e-03 | 14 | 108 | 2 | IPR003938 | |
| Domain | cNMP-bd_CS | 3.77e-03 | 16 | 108 | 2 | IPR018488 | |
| Domain | Frizzled/SFRP | 3.77e-03 | 16 | 108 | 2 | IPR015526 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 4.77e-03 | 18 | 108 | 2 | PS00754 | |
| Domain | SNF | 5.31e-03 | 19 | 108 | 2 | PF00209 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 5.31e-03 | 19 | 108 | 2 | PS00610 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 5.31e-03 | 19 | 108 | 2 | PS50267 | |
| Domain | Na/ntran_symport | 5.31e-03 | 19 | 108 | 2 | IPR000175 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 1.71e-13 | 32 | 85 | 9 | M27455 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 8.79e-12 | 31 | 85 | 8 | M877 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | CACNA1C SLC8A2 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A | 5.47e-09 | 130 | 85 | 10 | M27454 |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | CACNA1C XDH OPRM1 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A ABCD4 AKT2 | 2.77e-07 | 367 | 85 | 13 | M48346 |
| Pathway | REACTOME_MUSCLE_CONTRACTION | CACNA1C SLC8A2 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A | 3.76e-07 | 203 | 85 | 10 | M5485 |
| Pathway | WP_DRAVET_SYNDROME | 6.24e-07 | 28 | 85 | 5 | M45519 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 6.47e-07 | 121 | 85 | 8 | M872 | |
| Pathway | REACTOME_INTERFERON_GAMMA_SIGNALING | 2.00e-06 | 98 | 85 | 7 | M965 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC6A18 SLC4A7 SLC43A1 SLCO1B3 SLC6A11 SLC8A2 SLC12A4 SLC22A5 | 9.22e-05 | 238 | 85 | 8 | MM15076 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC6A18 SLC4A7 SLC43A1 SLCO1B3 SLC6A11 SLC8A2 SLC12A4 SLC22A5 | 1.26e-04 | 249 | 85 | 8 | M5988 |
| Pathway | KEGG_ABC_TRANSPORTERS | 1.39e-04 | 44 | 85 | 4 | M11911 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 2.37e-04 | 273 | 85 | 8 | M983 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC6A18 ABCC3 ABCA4 SLC4A7 SLC43A1 SLCO1B3 ADCY1 ABCA8 SLC6A11 SLC8A2 SLC12A4 SLC22A5 ANO3 | 4.38e-04 | 736 | 85 | 13 | M27287 |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 4.85e-04 | 108 | 85 | 5 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 5.06e-04 | 109 | 85 | 5 | MM15074 | |
| Pubmed | In silico genomic analysis of the human and murine guanylate-binding protein (GBP) gene clusters. | 1.95e-17 | 8 | 109 | 7 | 16689661 | |
| Pubmed | 8.74e-17 | 9 | 109 | 7 | 16382098 | ||
| Pubmed | Extensive characterization of IFN-induced GTPases mGBP1 to mGBP10 involved in host defense. | 7.97e-16 | 11 | 109 | 7 | 18025219 | |
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 8.24e-16 | 6 | 109 | 6 | 23652591 | |
| Pubmed | 4.13e-15 | 13 | 109 | 7 | 15123669 | ||
| Pubmed | Caspase-11 activation requires lysis of pathogen-containing vacuoles by IFN-induced GTPases. | 6.87e-14 | 9 | 109 | 6 | 24739961 | |
| Pubmed | A family of IFN-γ-inducible 65-kD GTPases protects against bacterial infection. | 1.19e-13 | 19 | 109 | 7 | 21551061 | |
| Pubmed | 2.76e-13 | 5 | 109 | 5 | 12396730 | ||
| Pubmed | Unique features of different members of the human guanylate-binding protein family. | 2.76e-13 | 5 | 109 | 5 | 17266443 | |
| Pubmed | 2.76e-13 | 5 | 109 | 5 | 21151871 | ||
| Pubmed | Guanylate binding proteins promote caspase-11-dependent pyroptosis in response to cytoplasmic LPS. | 3.76e-13 | 11 | 109 | 6 | 24715728 | |
| Pubmed | 7.50e-13 | 12 | 109 | 6 | 35906252 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | CACNA1C HCN4 HCN1 SCN1A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A | 2.28e-11 | 139 | 109 | 10 | 16985003 |
| Pubmed | 3.44e-11 | 9 | 109 | 5 | 15746173 | ||
| Pubmed | 4.31e-11 | 21 | 109 | 6 | 19158679 | ||
| Pubmed | 9.13e-11 | 4 | 109 | 4 | 17537961 | ||
| Pubmed | 9.13e-11 | 4 | 109 | 4 | 35031483 | ||
| Pubmed | 9.13e-11 | 4 | 109 | 4 | 29578003 | ||
| Pubmed | 9.13e-11 | 4 | 109 | 4 | 38404575 | ||
| Pubmed | 4.55e-10 | 5 | 109 | 4 | 8812438 | ||
| Pubmed | 4.55e-10 | 5 | 109 | 4 | 17724025 | ||
| Pubmed | Essential Role of mGBP7 for Survival of Toxoplasma gondii Infection. | 4.55e-10 | 5 | 109 | 4 | 31964735 | |
| Pubmed | Osteoclast fusion and bone loss are restricted by interferon inducible guanylate binding proteins. | 1.14e-08 | 9 | 109 | 4 | 33479228 | |
| Pubmed | 1.39e-08 | 25 | 109 | 5 | 35139355 | ||
| Pubmed | IRGB10 Liberates Bacterial Ligands for Sensing by the AIM2 and Caspase-11-NLRP3 Inflammasomes. | 2.96e-08 | 11 | 109 | 4 | 27693356 | |
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 19284629 | ||
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 33895391 | ||
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 23859570 | ||
| Pubmed | GTPase properties of the interferon-induced human guanylate-binding protein 2. | 2.99e-08 | 3 | 109 | 3 | 8706832 | |
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 32620042 | ||
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 29089068 | ||
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 1715024 | ||
| Pubmed | Two families of GTPases dominate the complex cellular response to IFN-gamma. | 2.99e-08 | 3 | 109 | 3 | 9862701 | |
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 11726669 | ||
| Pubmed | GBP2 inhibits pathological angiogenesis in the retina via the AKT/mTOR/VEGFA axis. | 2.99e-08 | 3 | 109 | 3 | 38636926 | |
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 15717119 | ||
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 35383115 | ||
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 20950129 | ||
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 12610651 | ||
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 30062052 | ||
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 26416908 | ||
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 32354743 | ||
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 19699781 | ||
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 18784617 | ||
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 17544618 | ||
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 32845893 | ||
| Pubmed | GBP3 promotes glioblastoma resistance to temozolomide by enhancing DNA damage repair. | 2.99e-08 | 3 | 109 | 3 | 35780181 | |
| Pubmed | Murine guanylate binding protein 2 (mGBP2) controls Toxoplasma gondii replication. | 2.99e-08 | 3 | 109 | 3 | 23248289 | |
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 28518218 | ||
| Pubmed | Domain motions, dimerization, and membrane interactions of the murine guanylate binding protein 2. | 2.99e-08 | 3 | 109 | 3 | 36639389 | |
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 17928448 | ||
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 14973256 | ||
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 16914101 | ||
| Pubmed | GBP3 promotes glioma cell proliferation via SQSTM1/p62-ERK1/2 axis. | 2.99e-08 | 3 | 109 | 3 | 29128363 | |
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 22730319 | ||
| Pubmed | Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. | 4.43e-08 | 12 | 109 | 4 | 30175250 | |
| Pubmed | 4.43e-08 | 12 | 109 | 4 | 29459437 | ||
| Pubmed | 4.75e-08 | 162 | 109 | 8 | 23012479 | ||
| Pubmed | 1.20e-07 | 4 | 109 | 3 | 10198179 | ||
| Pubmed | 1.20e-07 | 4 | 109 | 3 | 22260870 | ||
| Pubmed | 1.20e-07 | 4 | 109 | 3 | 8917111 | ||
| Pubmed | 1.20e-07 | 4 | 109 | 3 | 35801810 | ||
| Pubmed | 1.20e-07 | 4 | 109 | 3 | 39337476 | ||
| Pubmed | Interferon regulatory factor 1 is required for mouse Gbp gene activation by gamma interferon. | 1.20e-07 | 4 | 109 | 3 | 7823961 | |
| Pubmed | 1.20e-07 | 4 | 109 | 3 | 21156207 | ||
| Pubmed | 1.20e-07 | 4 | 109 | 3 | 36609599 | ||
| Pubmed | 1.20e-07 | 4 | 109 | 3 | 10386861 | ||
| Pubmed | Use of recombinant inbred strains for studying genetic determinants of responses to alcohol. | 1.20e-07 | 4 | 109 | 3 | 8974318 | |
| Pubmed | 1.21e-07 | 15 | 109 | 4 | 17114464 | ||
| Pubmed | 1.21e-07 | 15 | 109 | 4 | 25774716 | ||
| Pubmed | Confirmation of quantitative trait loci for alcohol preference in mice. | 1.21e-07 | 15 | 109 | 4 | 9726281 | |
| Pubmed | 2.11e-07 | 17 | 109 | 4 | 25774715 | ||
| Pubmed | 2.98e-07 | 5 | 109 | 3 | 1679748 | ||
| Pubmed | Early development of electrical excitability in the mouse enteric nervous system. | 2.98e-07 | 5 | 109 | 3 | 22875929 | |
| Pubmed | Murine GBP-2: a new IFN-gamma-induced member of the GBP family of GTPases isolated from macrophages. | 2.98e-07 | 5 | 109 | 3 | 9858320 | |
| Pubmed | 2.98e-07 | 5 | 109 | 3 | 24337656 | ||
| Pubmed | TCR Affinity Biases Th Cell Differentiation by Regulating CD25, Eef1e1, and Gbp2. | 2.98e-07 | 5 | 109 | 3 | 30858199 | |
| Pubmed | Interferon inducible GBPs restrict Burkholderia thailandensis motility induced cell-cell fusion. | 4.25e-07 | 20 | 109 | 4 | 32150572 | |
| Pubmed | 5.95e-07 | 6 | 109 | 3 | 16029194 | ||
| Pubmed | 5.95e-07 | 6 | 109 | 3 | 12111378 | ||
| Pubmed | 5.95e-07 | 6 | 109 | 3 | 23711479 | ||
| Pubmed | 5.95e-07 | 6 | 109 | 3 | 21757726 | ||
| Pubmed | 5.95e-07 | 6 | 109 | 3 | 17293456 | ||
| Pubmed | Diagnostic yield of genetic testing in epileptic encephalopathy in childhood. | 1.04e-06 | 7 | 109 | 3 | 25818041 | |
| Pubmed | TRIF signaling is required for caspase-11-dependent immune responses and lethality in sepsis. | 1.04e-06 | 7 | 109 | 3 | 30587103 | |
| Pubmed | 1.04e-06 | 7 | 109 | 3 | 21502320 | ||
| Pubmed | 1.04e-06 | 7 | 109 | 3 | 20505078 | ||
| Pubmed | Pain without nociceptors? Nav1.7-independent pain mechanisms. | 1.04e-06 | 7 | 109 | 3 | 24440715 | |
| Pubmed | 1.04e-06 | 7 | 109 | 3 | 23575686 | ||
| Pubmed | Evidence for the involvement of ASIC3 in sensory mechanotransduction in proprioceptors. | 1.66e-06 | 8 | 109 | 3 | 27161260 | |
| Pubmed | 1.66e-06 | 8 | 109 | 3 | 25101983 | ||
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | PTDSS1 TMEM119 ADCY1 CHRM4 TMEM101 OPRM1 ARHGDIG SLC8A2 GBP5 SERINC3 SMO TCTN2 | 2.04e-06 | 697 | 109 | 12 | 28298427 |
| Pubmed | Genetic mapping of the peripheral sodium channel genes, Scn9a and Scn10a, in the mouse. | 2.48e-06 | 9 | 109 | 3 | 8854872 | |
| Pubmed | Report and abstracts of the Fourth International Workshop on Human Chromosome 2 Mapping 1996. | 3.04e-06 | 71 | 109 | 5 | 8751373 | |
| Pubmed | Common variants associated with general and MMR vaccine-related febrile seizures. | 3.54e-06 | 10 | 109 | 3 | 25344690 | |
| Pubmed | Gβ2 Regulates the Multipolar-Bipolar Transition of Newborn Neurons in the Developing Neocortex. | 3.54e-06 | 10 | 109 | 3 | 28334111 | |
| Pubmed | 6.45e-06 | 12 | 109 | 3 | 8169823 | ||
| Pubmed | Identification and characterization of a new gene family induced during macrophage activation. | 9.73e-06 | 2 | 109 | 2 | 1753106 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 20346423 | ||
| Pubmed | Reduction of Kcnt1 is therapeutic in mouse models of SCN1A and SCN8A epilepsy. | 9.73e-06 | 2 | 109 | 2 | 37901435 | |
| Interaction | SCN11A interactions | 8.26e-09 | 15 | 101 | 5 | int:SCN11A | |
| Interaction | SCN9A interactions | 5.46e-08 | 21 | 101 | 5 | int:SCN9A | |
| Interaction | NEDD4L interactions | ERBB3 AICDA HCN1 PFKP TMEM101 NEDD4 SCN1A SCN2A SCN3A SCN8A SCN9A SCN10A | 7.05e-08 | 320 | 101 | 12 | int:NEDD4L |
| Interaction | SCN5A interactions | 1.24e-07 | 47 | 101 | 6 | int:SCN5A | |
| Interaction | ENTREP3 interactions | 1.59e-07 | 120 | 101 | 8 | int:ENTREP3 | |
| Interaction | SCN1A interactions | 3.09e-07 | 29 | 101 | 5 | int:SCN1A | |
| Interaction | YIPF3 interactions | GPM6A PIEZO1 SLC43A1 TMEM63C CHRM4 OPRM1 LMAN1 SLC22A5 SCN4A | 4.03e-07 | 186 | 101 | 9 | int:YIPF3 |
| Interaction | VNN2 interactions | 4.58e-06 | 49 | 101 | 5 | int:VNN2 | |
| Interaction | CACNA1D interactions | 5.85e-06 | 24 | 101 | 4 | int:CACNA1D | |
| Interaction | SCN4B interactions | 6.72e-06 | 8 | 101 | 3 | int:SCN4B | |
| Interaction | GBP7 interactions | 6.72e-06 | 8 | 101 | 3 | int:GBP7 | |
| Interaction | C18orf32 interactions | 1.43e-05 | 10 | 101 | 3 | int:C18orf32 | |
| Interaction | GBP3 interactions | 1.43e-05 | 10 | 101 | 3 | int:GBP3 | |
| Interaction | SCN10A interactions | 1.96e-05 | 11 | 101 | 3 | int:SCN10A | |
| Interaction | OR10H2 interactions | 3.07e-05 | 72 | 101 | 5 | int:OR10H2 | |
| Interaction | GBP5 interactions | 4.27e-05 | 14 | 101 | 3 | int:GBP5 | |
| Interaction | ADCK1 interactions | 4.81e-05 | 79 | 101 | 5 | int:ADCK1 | |
| Interaction | GBP1 interactions | 5.75e-05 | 42 | 101 | 4 | int:GBP1 | |
| Interaction | SCN8A interactions | 1.31e-04 | 20 | 101 | 3 | int:SCN8A | |
| Interaction | GBP2 interactions | 1.55e-04 | 54 | 101 | 4 | int:GBP2 | |
| Cytoband | 1p22.2 | 3.97e-13 | 28 | 109 | 7 | 1p22.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p22 | 1.51e-09 | 137 | 109 | 8 | chr1p22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 1.39e-05 | 127 | 109 | 5 | chr2q24 | |
| Cytoband | 2q24 | 3.03e-04 | 11 | 109 | 2 | 2q24 | |
| Cytoband | 2q24.3 | 6.56e-04 | 16 | 109 | 2 | 2q24.3 | |
| Cytoband | 16q22.1 | 2.34e-03 | 110 | 109 | 3 | 16q22.1 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 3.43e-16 | 9 | 70 | 7 | 1203 | |
| GeneFamily | Solute carriers | SLC6A18 SLC25A24 SLC4A7 SLC43A1 SLCO1B3 SLC6A11 SLC8A2 SLC12A4 SLC16A14 SLC22A5 SLC25A48 | 3.21e-07 | 395 | 70 | 11 | 752 |
| GeneFamily | Cyclic nucleotide gated channels | 6.52e-04 | 10 | 70 | 2 | 250 | |
| GeneFamily | G protein-coupled receptors, Class F frizzled | 7.95e-04 | 11 | 70 | 2 | 286 | |
| GeneFamily | ATP binding cassette subfamily A | 1.30e-03 | 14 | 70 | 2 | 805 | |
| Coexpression | SEKI_INFLAMMATORY_RESPONSE_LPS_UP | 7.38e-08 | 87 | 108 | 7 | MM1253 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_ENDOTHELIAL_CELL_AGEING | 1.59e-07 | 145 | 108 | 8 | MM3744 | |
| Coexpression | HOWARD_B_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP | 2.64e-07 | 14 | 108 | 4 | M41166 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | GPM6A CACNA1C NBEA MAST2 ADCY1 SLC8A2 SLC16A14 SCN2A SCN3A SCN8A SCN9A TENM1 MACROH2A2 | 8.70e-07 | 584 | 108 | 13 | M39068 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | GPM6A CACNA1C NBEA PFKP ADCY1 OPRM1 SLC8A2 SCN1A SCN2A SCN3A SCN7A SCN8A SCN9A TENM1 | 1.20e-06 | 703 | 108 | 14 | M39070 |
| Coexpression | ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP | 1.72e-06 | 138 | 108 | 7 | MM1047 | |
| Coexpression | GSE17721_PAM3CSK4_VS_GADIQUIMOD_24H_BMDC_DN | 1.83e-06 | 200 | 108 | 8 | M3981 | |
| Coexpression | GREENBAUM_E2A_TARGETS_DN | 1.88e-06 | 22 | 108 | 4 | MM635 | |
| Coexpression | DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP | ERBB3 PIEZO1 XDH NCAPG2 NEDD4 ERI3 SLC22A5 SCN10A TENM1 MED12 | 3.01e-06 | 368 | 108 | 10 | M16431 |
| Coexpression | ZEMEK_IMMUNE_CHECKPOINT_BLOCKADE_OVARIAN_CANCER_OVERLAP_UP | 3.29e-06 | 98 | 108 | 6 | MM460 | |
| Coexpression | ZEMEK_IMMUNE_CHECKPOINT_BLOCKADE_OVARIAN_CANCER_RENCA_UP | 3.70e-06 | 100 | 108 | 6 | MM458 | |
| Coexpression | MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_4_6MO_BCG_PRIMED_28DY_UP | 7.99e-06 | 10 | 108 | 3 | M41004 | |
| Coexpression | SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_7DY_DN | 1.02e-05 | 33 | 108 | 4 | M41194 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | GPM6A CACNA1C NBEA PFKP ADCY1 OPRM1 SLC8A2 MTMR6 PIEZO2 SCN1A SLC16A14 SCN2A SCN3A SCN8A SCN9A TENM1 | 1.20e-05 | 1106 | 108 | 16 | M39071 |
| Coexpression | MARKEY_RB1_ACUTE_LOF_DN | 1.53e-05 | 267 | 108 | 8 | MM1091 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_14_PRECICTIVE_ICB_RESPONSE | 1.85e-05 | 198 | 108 | 7 | MM17083 | |
| Coexpression | GSE7460_TCONV_VS_TREG_LN_DN | 1.97e-05 | 200 | 108 | 7 | M5674 | |
| Coexpression | HOWARD_T_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP | 2.70e-05 | 42 | 108 | 4 | M41024 | |
| Coexpression | WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN | 2.99e-05 | 15 | 108 | 3 | M15662 | |
| Coexpression | NAKAYA_PBMC_IMUVAC_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0DY_PREIMM_TIV_UP | 3.26e-05 | 44 | 108 | 4 | M40896 | |
| Coexpression | AFFAR_YY1_TARGETS_UP | 3.32e-05 | 217 | 108 | 7 | MM1156 | |
| Coexpression | MIKKELSEN_ES_ICP_WITH_H3K4ME3 | CUL4B GBP6 CHRNA9 TTLL9 TMEM63C TMEM119 ABCA8 OPRM1 SCN1A SCN9A TCTN2 FBXW7 | 4.70e-05 | 728 | 108 | 12 | M2004 |
| Coexpression | HOWARD_DENDRITIC_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP | 5.21e-05 | 159 | 108 | 6 | M40998 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP | 5.51e-05 | 235 | 108 | 7 | MM978 | |
| Coexpression | GSE35825_IFNA_VS_IFNG_STIM_MACROPHAGE_UP | 5.98e-05 | 163 | 108 | 6 | M8663 | |
| Coexpression | FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON | 6.62e-05 | 166 | 108 | 6 | M39026 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_UP | 8.57e-05 | 21 | 108 | 3 | MM651 | |
| Coexpression | GSE34156_UNTREATED_VS_6H_NOD2_LIGAND_TREATED_MONOCYTE_DN | 9.43e-05 | 177 | 108 | 6 | M8666 | |
| Coexpression | GSE14415_INDUCED_TREG_VS_FAILED_INDUCED_TREG_DN | 9.73e-05 | 178 | 108 | 6 | M2952 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HSERT | 1.04e-04 | 450 | 108 | 9 | M39072 | |
| Coexpression | ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP | 1.16e-04 | 115 | 108 | 5 | M5487 | |
| Coexpression | MIKKELSEN_ES_ICP_WITH_H3K4ME3 | CUL4B GBP6 CHRNA9 TTLL9 TMEM63C TMEM119 ABCA8 OPRM1 SCN1A SCN9A TCTN2 FBXW7 | 1.25e-04 | 807 | 108 | 12 | MM855 |
| Coexpression | HOWARD_NEUTROPHIL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_UP | 1.36e-04 | 119 | 108 | 5 | M41109 | |
| Coexpression | HU_FETAL_RETINA_AMACRINE | 1.43e-04 | 64 | 108 | 4 | M39261 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP | 1.46e-04 | 25 | 108 | 3 | MM672 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA1_UP | 1.53e-04 | 122 | 108 | 5 | M9399 | |
| Coexpression | SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_UP | 1.65e-04 | 26 | 108 | 3 | M41741 | |
| Coexpression | GSE3982_MAST_CELL_VS_TH1_DN | 1.74e-04 | 198 | 108 | 6 | M5454 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_CXCL9_POS_MACROPHAGE_CELL | 1.78e-04 | 126 | 108 | 5 | M45721 | |
| Coexpression | GSE15733_BM_VS_SPLEEN_MEMORY_CD4_TCELL_UP | 1.84e-04 | 200 | 108 | 6 | M3568 | |
| Coexpression | GSE7852_TREG_VS_TCONV_LN_UP | 1.84e-04 | 200 | 108 | 6 | M5727 | |
| Coexpression | ZHONG_PFC_C3_ASTROCYTE | 2.12e-04 | 389 | 108 | 8 | M39102 | |
| Coexpression | GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_2H_DN | 2.37e-04 | 134 | 108 | 5 | M8174 | |
| Coexpression | SEKI_INFLAMMATORY_RESPONSE_LPS_UP | 2.78e-04 | 76 | 108 | 4 | M7245 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA1_UP | 3.20e-04 | 143 | 108 | 5 | MM1056 | |
| Coexpression | GSE12507_PDC_CELL_LINE_VS_IMMATUE_T_CELL_LINE_DN | 3.30e-04 | 144 | 108 | 5 | M440 | |
| Coexpression | VAN_DEN_BIGGELAAR_PBMC_PREVNAR_9MO_INFANT_STIMULATED_VS_UNSTIMULATED_8MO_UP | 3.55e-04 | 81 | 108 | 4 | M40892 | |
| Coexpression | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP | 4.08e-04 | 84 | 108 | 4 | MM1049 | |
| Coexpression | MARKEY_RB1_ACUTE_LOF_DN | 4.16e-04 | 233 | 108 | 6 | M7094 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_500 | GPM6A GBP6 GBP7 GBP1 XDH GBP2 TMEM119 TMTC1 PIEZO2 GBP4 ACKR3 SCN2A | 4.94e-07 | 408 | 100 | 12 | gudmap_kidney_adult_RenalCapsule_500 |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_1000 | GPM6A GBP6 GBP7 PIEZO1 GBP1 XDH GBP2 TMEM119 PFKP ABCA8 TMTC1 PIEZO2 GBP4 GBP5 ACKR3 SCN2A | 6.88e-07 | 778 | 100 | 16 | gudmap_kidney_adult_RenalCapsule_1000 |
| CoexpressionAtlas | BM Top 100 - occipital lobe | 1.24e-06 | 73 | 100 | 6 | BM Top 100 - occipital lobe | |
| CoexpressionAtlas | kidney_adult_GlomCapSys_Tie2_k-means-cluster#3_top-relative-expression-ranked_500 | 3.48e-06 | 87 | 100 | 6 | gudmap_kidney_adult_GlomCapSys_Tie2_k3_500 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#4_top-relative-expression-ranked_500 | 1.28e-05 | 64 | 100 | 5 | gudmap_kidney_adult_RenalCapsule_k4_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.50e-05 | 234 | 100 | 8 | gudmap_developingKidney_e15.5_Peripheral blastema_1000_k2 | |
| CoexpressionAtlas | kidney_adult_RenMedVasc_Tie2_k-means-cluster#4_top-relative-expression-ranked_200 | 1.71e-05 | 33 | 100 | 4 | gudmap_kidney_adult_RenMedVasc_Tie2_k4_200 | |
| CoexpressionAtlas | kidney_adult_CortVasc_Tie2_k-means-cluster#4_top-relative-expression-ranked_100 | 5.43e-05 | 16 | 100 | 3 | gudmap_kidney_adult_CortVasc_Tie2_k4_100 | |
| CoexpressionAtlas | kidney_adult_CortVasc_Tie2_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.44e-05 | 44 | 100 | 4 | gudmap_kidney_adult_CortVasc_Tie2_k3_1000 | |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_k-means-cluster#1_top-relative-expression-ranked_200 | 5.95e-05 | 45 | 100 | 4 | gudmap_kidney_adult_Mesangium_Meis_k1_200 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#1_top-relative-expression-ranked_200 | 1.27e-04 | 21 | 100 | 3 | gudmap_kidney_adult_RenalCapsule_k1_200 | |
| CoexpressionAtlas | kidney_adult_RenMedVasc_Tie2_top-relative-expression-ranked_200 | 1.64e-04 | 172 | 100 | 6 | gudmap_kidney_adult_RenMedVasc_Tie2_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#3_top-relative-expression-ranked_100 | 1.84e-04 | 60 | 100 | 4 | gudmap_developingKidney_e15.5_Peripheral blastema_100_k3 | |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_k-means-cluster#4_top-relative-expression-ranked_100 | 2.18e-04 | 5 | 100 | 2 | gudmap_kidney_adult_Mesangium_Meis_k4_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#2_top-relative-expression-ranked_200 | 2.22e-04 | 116 | 100 | 5 | gudmap_developingKidney_e15.5_Peripheral blastema_200_k2 | |
| CoexpressionAtlas | cerebral cortex | GPM6A LRFN1 HCN4 HCN1 TMEM63C NBEA ADCY1 CHRM4 SLC6A11 ARHGDIG SLC8A2 SCN1A SCN2A SCN3A SCN8A RORB SLC25A48 | 3.44e-04 | 1428 | 100 | 17 | cerebral cortex |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.57e-04 | 369 | 100 | 8 | gudmap_kidney_adult_RenalCapsule_k2_1000 | |
| CoexpressionAtlas | BM Top 100 - cerebral cortex | 3.73e-04 | 72 | 100 | 4 | BM Top 100 - cerebral cortex | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#3_top-relative-expression-ranked_500 | 3.93e-04 | 73 | 100 | 4 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k3_500 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_k-means-cluster#5_top-relative-expression-ranked_200 | 4.14e-04 | 31 | 100 | 3 | gudmap_developingKidney_e11.5_ureteric bud_200_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#2_top-relative-expression-ranked_500 | 4.33e-04 | 206 | 100 | 6 | gudmap_developingKidney_e15.5_Peripheral blastema_500_k2 | |
| CoexpressionAtlas | BM Top 100 - parietal lobe | 4.36e-04 | 75 | 100 | 4 | BM Top 100 - parietal lobe | |
| CoexpressionAtlas | kidney_adult_CortVasc_Tie2_k-means-cluster#2_top-relative-expression-ranked_500 | 4.58e-04 | 76 | 100 | 4 | gudmap_kidney_adult_CortVasc_Tie2_k2_500 | |
| CoexpressionAtlas | kidney_adult_CortVasc_Tie2_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.95e-04 | 138 | 100 | 5 | gudmap_kidney_adult_CortVasc_Tie2_k4_1000 | |
| CoexpressionAtlas | kidney_adult_GlomCapSys_Tie2_k-means-cluster#4_top-relative-expression-ranked_200 | 4.99e-04 | 33 | 100 | 3 | gudmap_kidney_adult_GlomCapSys_Tie2_k4_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29965_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.80e-04 | 303 | 100 | 7 | gudmap_developingKidney_e15.5_Endothelial cells_1000_k1 | |
| ToppCell | Endothelial-Endothelial-F|Endothelial / shred on cell class and cell subclass (v4) | 2.15e-08 | 122 | 109 | 7 | 2cb8bb63c69aed4d4504b9d97219b8707666f950 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.17e-08 | 198 | 109 | 8 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.17e-08 | 198 | 109 | 8 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Endothelial-F|World / shred on cell class and cell subclass (v4) | 5.29e-08 | 139 | 109 | 7 | 32d3c5d35e6c4205711c3500d736fd108443e6b4 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-07 | 178 | 109 | 7 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-07 | 187 | 109 | 7 | 7b2cd0c618ed081223343f3bec2244c8723c9a31 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.86e-07 | 198 | 109 | 7 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.86e-07 | 198 | 109 | 7 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Lymphatic|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 6.06e-07 | 199 | 109 | 7 | 88f33b8dcd837abfa1d12c28719e073a7da6e979 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Lymphatic|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.06e-07 | 199 | 109 | 7 | 64b19aff72e2a109cb5857cb248bd4712dd49b43 | |
| ToppCell | Neuron|World / Primary Cells by Cluster | 6.06e-07 | 199 | 109 | 7 | 1f8104fd92f04690b41d9d07ac08dc59d76bb97d | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Lymphatic-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.06e-07 | 199 | 109 | 7 | 2b9e1e069b36b3a61cc3e384f4523687b0e03905 | |
| ToppCell | Neuron-Postmitotic|World / Primary Cells by Cluster | 6.06e-07 | 199 | 109 | 7 | 1973527f8a7d4c6490d75c0d0ea153688166a08b | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.27e-07 | 200 | 109 | 7 | 0f6620a5baace704518d42fa2f3f90751240f7dd | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer|World / Primary Cells by Cluster | 6.27e-07 | 200 | 109 | 7 | db10f76938af553d1a2275bb02ef75dff3c3135b | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21|World / Primary Cells by Cluster | 6.27e-07 | 200 | 109 | 7 | 30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.96e-06 | 162 | 109 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c5-GSTP1(high)OASL(low)|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.91e-06 | 170 | 109 | 6 | 07b561cd9c528bc8444c9385e1de621eee7b697e | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-neuro-epithelial|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.32e-06 | 173 | 109 | 6 | 07798461d12d04f3dabff03481c999cb07c5af2f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.93e-06 | 177 | 109 | 6 | ca5a30b3e7bcfdd8de01ceaf7449735b5cd503af | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.93e-06 | 177 | 109 | 6 | f471f7747d6e8db7546899019af9508f48a14f89 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.93e-06 | 177 | 109 | 6 | cd0684b876c2a7d5fe7e2773e8e25bb61ecbc795 | |
| ToppCell | COVID-19-Heart-Lymph_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.93e-06 | 177 | 109 | 6 | 326fde0734ef0d7272693966d346ca479b9d8147 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.09e-06 | 178 | 109 | 6 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.43e-06 | 180 | 109 | 6 | f6a2208960d0df1500c974cc44c3c054cd7475a9 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.60e-06 | 181 | 109 | 6 | e898ecb8d8f2eb2204225b7b0d665cadcd241139 | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 5.78e-06 | 182 | 109 | 6 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.16e-06 | 184 | 109 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.16e-06 | 184 | 109 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.16e-06 | 184 | 109 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.55e-06 | 186 | 109 | 6 | 20340a5b5cc7f07386498a4ef937d6fbc9e347c4 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.55e-06 | 186 | 109 | 6 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.75e-06 | 187 | 109 | 6 | 7abc174a06bf07b5f6efe0a370fbb1c23e0079b3 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.75e-06 | 187 | 109 | 6 | f9863428943b695f26bd680e6fc5aeb38ec3422f | |
| ToppCell | critical-Myeloid-Monocyte-derived_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.75e-06 | 187 | 109 | 6 | 72e4aec49ea0c5fe6cee2a1a46369dbc90cd3fad | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.75e-06 | 187 | 109 | 6 | b0a2e417b4eb9a185033e89c5df3431c11488688 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_monocytic-non-classical_monocyte|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.95e-06 | 108 | 109 | 5 | 695ed3f8cf637d767a6d79b0309d5ee82dfd063f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.96e-06 | 188 | 109 | 6 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.18e-06 | 189 | 109 | 6 | f57200c93d39c9bce1adba0a6a1c178c028dd86b | |
| ToppCell | 15-Trachea-Epithelial-Neuroendocrine|Trachea / Age, Tissue, Lineage and Cell class | 7.62e-06 | 191 | 109 | 6 | 76311fa5f3ae9bb27cf04387a8c92300f2888c28 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.62e-06 | 191 | 109 | 6 | a7b18bcf27c38ad2353c239ecb309c80f3ef3359 | |
| ToppCell | COVID-19-lung-Lymphatic_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.85e-06 | 192 | 109 | 6 | cbe57cda44232b183821ac633b60a2668265e616 | |
| ToppCell | Leuk-UTI|World / Disease, Lineage and Cell Type | 8.09e-06 | 193 | 109 | 6 | 26119a0b5d7684022fd16b8b73a0ef5a7d70f3d1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.09e-06 | 193 | 109 | 6 | 5fb7808dd971c1cc64c2bd4f8f1de646fb2d77f4 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.83e-06 | 196 | 109 | 6 | 09a7edf4a7defb7fe70d9777dd9500ee8421ff31 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.83e-06 | 196 | 109 | 6 | e50d2c66d5c5cd25fdfecdcc4c8506a1d0a85755 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.83e-06 | 196 | 109 | 6 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | LAM-Endothelial-LymEndo|Endothelial / Condition, Lineage and Cell class | 9.36e-06 | 198 | 109 | 6 | ba64b1c95dfaa995045239d412e725596f6c482e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.36e-06 | 198 | 109 | 6 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 9.63e-06 | 199 | 109 | 6 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 9.63e-06 | 199 | 109 | 6 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_|World / Primary Cells by Cluster | 9.63e-06 | 199 | 109 | 6 | 058373b4ac3cec2108cb24265628ff0a50646e33 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 9.91e-06 | 200 | 109 | 6 | bad32a95b759fad509401b07bc96a56687c2a592 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 9.91e-06 | 200 | 109 | 6 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.91e-06 | 200 | 109 | 6 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Cortical_neuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 9.91e-06 | 200 | 109 | 6 | 68c90376e2779434e4ad8dc6dd3b44baa700e2f4 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 9.91e-06 | 200 | 109 | 6 | 5c7263c862093ad9dbc81d06b16b6f74e8a6b634 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.91e-06 | 200 | 109 | 6 | fb53be20392a8309a7393774c774a1b1aec6e676 | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_STALK-Flt1_1|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.20e-05 | 137 | 109 | 5 | 306b11b3b9e5fd562d845fb5eaa4ac982864efce | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_STALK|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.20e-05 | 137 | 109 | 5 | d37f425b13bc046baa1f8619b98a16b936f88ff6 | |
| ToppCell | Healthy-CD4+_T_activated|Healthy / disease group, cell group and cell class | 2.89e-05 | 145 | 109 | 5 | 45e8089fdf7d6f69b383816d8945e39fba24c873 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.89e-05 | 145 | 109 | 5 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-H-|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.63e-05 | 152 | 109 | 5 | dbfb4d4de36ef9f5c7da1950baa915b12788685e | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.63e-05 | 152 | 109 | 5 | 5adcdf93fd3ca066402aaaf308c363e4648f871d | |
| ToppCell | 368C-Fibroblasts-Fibroblast-H|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.63e-05 | 152 | 109 | 5 | 9f3682da00fd627e80aa820ecc6f5fed23b9738a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.23e-05 | 157 | 109 | 5 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.36e-05 | 158 | 109 | 5 | e5636c0b608d68bd426a2b446ac508e4512e86a4 | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-HSC/MPP_and_pro|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.06e-05 | 163 | 109 | 5 | edca1d1a345109dbdeb7ee5464faefab1993fdb2 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.06e-05 | 163 | 109 | 5 | 130c84bca3f72ab7d1a4fee2990c3d01600318ed | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Pleural_Mac|Myeloid_cells / Location, Cell class and cell subclass | 5.21e-05 | 164 | 109 | 5 | 362c16ed7fb37bf16601fd5e059d3f3e2ed692b4 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 5.36e-05 | 165 | 109 | 5 | 7d319a112b9062efee428bef6f4534d2ce782e04 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-05 | 166 | 109 | 5 | 548d0d6c0ffd564036ddba78620734220ebb73d7 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-05 | 166 | 109 | 5 | 80e164a89d22098cabe4a99a78283ba69ea0561e | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Rectum_normal_tissue-Rectum_normal_tissue-6|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 5.84e-05 | 168 | 109 | 5 | 5ce3129a023a48a3d7e6b9306c1fc5addfef9675 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.84e-05 | 168 | 109 | 5 | 95dc690c1987b05685d36e6bb20eb79308696e30 | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-HSC/MPP_and_pro-ELP|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.18e-05 | 170 | 109 | 5 | a50e558d0b38100ccbdccb90647fe93e85bffd86 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-5_RORB_CMAHP|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.35e-05 | 171 | 109 | 5 | 9d5cabd71a901a00eb16c4d151189296f1b3bf6f | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.53e-05 | 172 | 109 | 5 | c96bd3407911df3e3e6d7a3dba786b11814b9598 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.89e-05 | 174 | 109 | 5 | 0fccd90ef72ec2e5eb369fe6d6d126c60886485a | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.08e-05 | 175 | 109 | 5 | 97616bb5c127284aa9e67bc336dfcf29e137164b | |
| ToppCell | Monocytes-IFN-activated_Monocytes|Monocytes / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 7.28e-05 | 176 | 109 | 5 | 6a4b403ee3e4dc4f23fbd7a154011e41fd429a9e | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.28e-05 | 176 | 109 | 5 | eb63eb2c301e785196ccadac74a2940b2c524c62 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.47e-05 | 177 | 109 | 5 | d05497d2c80a66ec6a4e1733fea3a5534877a6a7 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.88e-05 | 179 | 109 | 5 | d1365d48d1b017a7917f4f63a82ac4720c3d87df | |
| ToppCell | COVID-19-Heart-Lymph_EC|Heart / Disease (COVID-19 only), tissue and cell type | 7.88e-05 | 179 | 109 | 5 | 411620201a860716a8773b92f50f7b94ef34a586 | |
| ToppCell | -Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 7.88e-05 | 179 | 109 | 5 | e4224b2e9c4ae7da62cf670adf811f4112c7d060 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.52e-05 | 182 | 109 | 5 | ecb5624c9074cc6449fad961df54c926c2681d54 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.52e-05 | 182 | 109 | 5 | 41b070085edba7a58b81c20aa4942d06f745acf8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.52e-05 | 182 | 109 | 5 | 5e9a67b2de0daa4fdc344b10a857d8a901ad810e | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l19|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.52e-05 | 182 | 109 | 5 | 840427d1c23d60482c943ff006b14007ed44d247 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.52e-05 | 182 | 109 | 5 | b0fe042c71d6ab8c75abd7ba9d2de00b72d01c0c | |
| ToppCell | NS-moderate-d_07-13-Myeloid-Monocyte-derived_Macrophage|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.52e-05 | 182 | 109 | 5 | e03e995e5fd14fc6a7559b83c0ca4e7ccc8e3d0f | |
| ToppCell | COVID-19-kidney-Mito-rich_EC|kidney / Disease (COVID-19 only), tissue and cell type | 8.75e-05 | 183 | 109 | 5 | 3c4153479fc4ab2d073d92cee120480015555914 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.75e-05 | 183 | 109 | 5 | 4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 8.75e-05 | 183 | 109 | 5 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | droplet-Trachea-nan-3m-Endothelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.97e-05 | 184 | 109 | 5 | fa5c3020e75fdde1363393dea97ebd99f1eae9ff | |
| ToppCell | droplet-Lung-3m-Epithelial-airway_epithelial-neuroendocrine_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.97e-05 | 184 | 109 | 5 | e0e5a553fb8c0947679634396d20c2ca8455b932 | |
| ToppCell | droplet-Trachea-3m-Endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.97e-05 | 184 | 109 | 5 | ad520ab6bb776b5303df505b7e1afb22484f18a7 | |
| ToppCell | droplet-Trachea-nan-3m-Endothelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.97e-05 | 184 | 109 | 5 | 1d63cb75a89c5f3f3b9ebf7fce8cb0fd4a92b645 | |
| ToppCell | droplet-Trachea-nan-3m-Endothelial-endothelial_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.97e-05 | 184 | 109 | 5 | 76caad53d55fff5acca27bf190a6de7b27437d9f | |
| Drug | APETx1, Anthopleura elegantissima | 1.31e-11 | 6 | 108 | 5 | ctd:C475726 | |
| Drug | sodium | SLC6A18 GABRE CACNA1C ABCC3 SLC4A7 CHRNA9 HCN1 SLCO1B3 ADCY1 NEDD4 SLC6A11 SLC8A2 SLC12A4 SCN2A SCN3A SLC22A5 SCN4A SCN7A SCN9A SCN10A RPL9 | 3.01e-09 | 944 | 108 | 21 | CID000000923 |
| Drug | Zonisamide | 1.29e-08 | 17 | 108 | 5 | DB00909 | |
| Drug | NSC7524 | CACNA1C CHRNA9 ADCY1 SLC6A11 SCN2A SCN3A SCN4A SCN7A SCN9A SCN10A | 1.64e-08 | 182 | 108 | 10 | CID000005657 |
| Drug | benzocaine | 2.04e-08 | 37 | 108 | 6 | CID000002337 | |
| Drug | diprafenone | 2.41e-08 | 19 | 108 | 5 | CID000071249 | |
| Drug | aprindine | 2.42e-08 | 38 | 108 | 6 | CID000002218 | |
| Drug | 2,3,5,6-tetrafluoro-4-methylbenzyl (Z)-(1RS)-cis-3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate | 3.30e-08 | 8 | 108 | 4 | ctd:C489827 | |
| Drug | pilsicainide | 7.95e-08 | 46 | 108 | 6 | CID000004820 | |
| Drug | spiradoline | 7.95e-08 | 46 | 108 | 6 | CID000005620 | |
| Drug | N-(2-methyl-3-(4-(4-(4-(trifluoromethoxy)benzyloxy)piperidin-1-yl)-1,3,5-triazin-2-ylamino)phenyl)acetamide | 1.04e-07 | 3 | 108 | 3 | ctd:C561228 | |
| Drug | AC1NT1AF | 1.08e-07 | 25 | 108 | 5 | CID005322157 | |
| Drug | tetradotoxin | GABRE CACNA1C CHRNA9 HCN1 OPRM1 SLC6A11 SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A | 1.25e-07 | 428 | 108 | 13 | CID000020382 |
| Drug | Pirmenolum | 1.33e-07 | 26 | 108 | 5 | CID000004853 | |
| Drug | PbTx-1 | 1.63e-07 | 27 | 108 | 5 | CID006437089 | |
| Drug | AC1L1MOZ | 1.63e-07 | 27 | 108 | 5 | CID000031958 | |
| Drug | nefopam | 1.63e-07 | 27 | 108 | 5 | CID000004450 | |
| Drug | carbamazepine | 1.88e-07 | 179 | 108 | 9 | CID000002554 | |
| Drug | paraben | 1.97e-07 | 28 | 108 | 5 | CID000007175 | |
| Drug | tocainide | 2.84e-07 | 30 | 108 | 5 | CID000038945 | |
| Drug | propofol | 3.26e-07 | 191 | 108 | 9 | CID000004943 | |
| Drug | triamterene | 3.28e-07 | 58 | 108 | 6 | CID000005546 | |
| Drug | NSC93767 | 3.98e-07 | 32 | 108 | 5 | CID000005658 | |
| Drug | APETx2 protein, Anthopleura elegantissima | 4.14e-07 | 4 | 108 | 3 | ctd:C501880 | |
| Drug | decamethrin | 4.83e-07 | 146 | 108 | 8 | ctd:C017180 | |
| Drug | zonisamide | 4.91e-07 | 62 | 108 | 6 | CID000005734 | |
| Drug | 5-hydroxypropafenone | 5.46e-07 | 34 | 108 | 5 | CID000107927 | |
| Drug | verapamil | CACNA1C ABCC3 ABCA4 CHRNA9 ADCY1 ABCA8 SCN3A SLC22A5 SCN4A SCN7A SCN9A SCN10A ABCD4 | 5.81e-07 | 490 | 108 | 13 | CID000002520 |
| Drug | saxitoxin | 6.52e-07 | 65 | 108 | 6 | CID000037165 | |
| Drug | disopyramide | 7.14e-07 | 66 | 108 | 6 | CID000003114 | |
| Drug | pentobarbital | 1.24e-06 | 224 | 108 | 9 | CID000004737 | |
| Drug | S-ropivacaine | 1.26e-06 | 40 | 108 | 5 | CID000071273 | |
| Drug | lamotrigine | 1.35e-06 | 116 | 108 | 7 | CID000003878 | |
| Drug | Scorpion Venoms | 1.39e-06 | 18 | 108 | 4 | ctd:D012604 | |
| Drug | gabapentin | 1.46e-06 | 169 | 108 | 8 | CID000003446 | |
| Drug | fenpropathrin | 2.05e-06 | 6 | 108 | 3 | ctd:C044267 | |
| Drug | bupivacaine | 2.24e-06 | 125 | 108 | 7 | CID000002474 | |
| Drug | bepridil | 2.36e-06 | 126 | 108 | 7 | CID000002351 | |
| Drug | bupropion | 2.41e-06 | 81 | 108 | 6 | CID000000444 | |
| Drug | Sodium | 2.98e-06 | 84 | 108 | 6 | ctd:D012964 | |
| Drug | indoxacarb | 3.53e-06 | 49 | 108 | 5 | CID000107720 | |
| Drug | potassium | CUL4B CACNA1C CHRNA9 HCN1 ADCY1 SLC8A2 MTMR6 SLC12A4 MRPS2 SCN2A SCN3A SCN4A SCN7A SCN9A SCN10A AKT2 RPL9 | 5.20e-06 | 1008 | 108 | 17 | CID000000813 |
| Drug | clenbuterol | 5.22e-06 | 142 | 108 | 7 | CID000002783 | |
| Drug | AC1NSN3X | 5.75e-06 | 54 | 108 | 5 | CID005366189 | |
| Drug | isoflurane | 7.43e-06 | 279 | 108 | 9 | CID000003763 | |
| Drug | isradipine | 8.22e-06 | 100 | 108 | 6 | CID000003784 | |
| Drug | procaine | 8.52e-06 | 153 | 108 | 7 | CID000004914 | |
| Drug | Mexiletine | 8.54e-06 | 9 | 108 | 3 | ctd:D008801 | |
| Drug | 6-chloro-6-deoxymannose | 8.54e-06 | 9 | 108 | 3 | CID000021090 | |
| Drug | AC1NPPZW | 9.75e-06 | 103 | 108 | 6 | CID005183170 | |
| Drug | methylglucamine | 1.14e-05 | 62 | 108 | 5 | CID000004049 | |
| Drug | AC1L1CQC | 1.44e-05 | 65 | 108 | 5 | CID000002012 | |
| Drug | mexiletine | 1.55e-05 | 66 | 108 | 5 | CID000004178 | |
| Drug | resiniferatoxin | 1.55e-05 | 66 | 108 | 5 | CID000104826 | |
| Drug | dibucaine | 1.80e-05 | 68 | 108 | 5 | CID000003025 | |
| Drug | GBR 12909 | 1.93e-05 | 69 | 108 | 5 | CID000003455 | |
| Drug | amiloride | 1.95e-05 | 315 | 108 | 9 | CID000016230 | |
| Drug | riluzole | 1.97e-05 | 174 | 108 | 7 | CID000005070 | |
| Drug | T2755 | 2.22e-05 | 71 | 108 | 5 | CID000005514 | |
| Drug | flecainide | 2.22e-05 | 71 | 108 | 5 | CID000003355 | |
| Drug | mu-conotoxin KIIIA, Conus kinoshitai | 2.23e-05 | 2 | 108 | 2 | ctd:C502265 | |
| Drug | hydrochlorothiazide | 2.33e-05 | 120 | 108 | 6 | CID000003639 | |
| Drug | strychnine HCl | 2.53e-05 | 181 | 108 | 7 | CID000005304 | |
| Drug | 1, 3-diallylurea | 2.72e-05 | 74 | 108 | 5 | CID000074537 | |
| Drug | imide | 2.72e-05 | 74 | 108 | 5 | CID000443040 | |
| Drug | sipatrigine | 2.80e-05 | 37 | 108 | 4 | CID000060803 | |
| Drug | diphenhydramine | 2.90e-05 | 75 | 108 | 5 | CID000003100 | |
| Drug | procainamide | 3.46e-05 | 190 | 108 | 7 | CID000004913 | |
| Drug | beta-hydroxy simvastatin acid | 3.51e-05 | 78 | 108 | 5 | ctd:C483161 | |
| Drug | ketamine | 3.61e-05 | 262 | 108 | 8 | CID000003821 | |
| Drug | bioallethrin | 3.64e-05 | 14 | 108 | 3 | ctd:C018465 | |
| Drug | Tetrodotoxin | 3.84e-05 | 40 | 108 | 4 | ctd:D013779 | |
| Drug | ethanol | GABRE CACNA1C ERBB3 CHRNA9 XDH PFKL PFKP ADCY1 OPRM1 SCN3A SCN4A SCN7A SCN9A SCN10A | 4.19e-05 | 837 | 108 | 14 | CID000000702 |
| Drug | zolpidem | 5.12e-05 | 43 | 108 | 4 | CID000005732 | |
| Drug | lactate | PFKL PFKP MRPS2 SLC16A14 SCN3A SCN4A SCN7A SCN9A SCN10A RPL9 | 6.93e-05 | 461 | 108 | 10 | CID000000612 |
| Drug | salbutamol | 7.01e-05 | 146 | 108 | 6 | CID000002083 | |
| Drug | quindine | 8.48e-05 | 219 | 108 | 7 | CID000001065 | |
| Drug | phenytoin | 8.48e-05 | 219 | 108 | 7 | CID000001775 | |
| Drug | AC1NRC8M | 9.52e-05 | 19 | 108 | 3 | CID005288877 | |
| Drug | drosopterin | 9.52e-05 | 19 | 108 | 3 | CID000189089 | |
| Drug | propafenone | 1.05e-04 | 98 | 108 | 5 | CID000004932 | |
| Drug | trimethoprim | 1.10e-04 | 99 | 108 | 5 | CID000005578 | |
| Drug | lidocaine | 1.16e-04 | 160 | 108 | 6 | CID000003676 | |
| Drug | amiodarone | 1.16e-04 | 160 | 108 | 6 | CID000002156 | |
| Drug | Lidocaine | 1.33e-04 | 4 | 108 | 2 | DB00281 | |
| Drug | diphenoxylate | 1.33e-04 | 4 | 108 | 2 | CID000013505 | |
| Drug | Propofol | 1.33e-04 | 4 | 108 | 2 | DB00818 | |
| Drug | Fospropofol | 1.33e-04 | 4 | 108 | 2 | DB06716 | |
| Drug | Uridine diphosphate 2-deoxyglucose | 1.33e-04 | 4 | 108 | 2 | CID000165519 | |
| Drug | Verapamil | 1.45e-04 | 105 | 108 | 5 | ctd:D014700 | |
| Drug | estradiol-17 beta-glucuronide | 1.50e-04 | 22 | 108 | 3 | ctd:C025483 | |
| Drug | pyraclofos | 1.52e-04 | 106 | 108 | 5 | CID000093460 | |
| Drug | monomethyl phthalate | ABCC3 ERBB3 GBP6 GBP1 XDH MAST2 ADCY1 GBP4 SLC12A4 SCN2A SCN8A SERINC3 TFB2M FBXW7 | 1.73e-04 | 957 | 108 | 14 | ctd:C517284 |
| Drug | Probenecid | 1.78e-04 | 59 | 108 | 4 | ctd:D011339 | |
| Drug | toluene | 1.89e-04 | 175 | 108 | 6 | CID000001140 | |
| Drug | polyribosylribitol phosphate | 1.96e-04 | 112 | 108 | 5 | CID000002219 | |
| Drug | fenfluramine | 2.08e-04 | 178 | 108 | 6 | CID000003337 | |
| Drug | gamma-Aminobutyric Acid | 2.16e-04 | 62 | 108 | 4 | ctd:D005680 | |
| Drug | soybean oil, phospholipid emulsion | 2.21e-04 | 5 | 108 | 2 | ctd:C545823 | |
| Drug | AR18 | 2.21e-04 | 5 | 108 | 2 | CID000114011 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 7.47e-19 | 10 | 103 | 8 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 7.47e-19 | 10 | 103 | 8 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 8.17e-18 | 12 | 103 | 8 | DOID:0060170 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 6.18e-09 | 163 | 103 | 9 | DOID:1826 (implicated_via_orthology) | |
| Disease | anxiety disorder (implicated_via_orthology) | 1.18e-08 | 22 | 103 | 5 | DOID:2030 (implicated_via_orthology) | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 1.74e-08 | 9 | 103 | 4 | C3502809 | |
| Disease | Seizure, Febrile, Simple | 1.43e-06 | 7 | 103 | 3 | C0149886 | |
| Disease | Seizure, Febrile, Complex | 1.43e-06 | 7 | 103 | 3 | C0751057 | |
| Disease | Epilepsy | 2.36e-06 | 109 | 103 | 6 | C0014544 | |
| Disease | Febrile Convulsions | 3.42e-06 | 9 | 103 | 3 | C0009952 | |
| Disease | Shortened QT interval | 6.68e-06 | 11 | 103 | 3 | C0151879 | |
| Disease | Epilepsy, Cryptogenic | 1.04e-05 | 82 | 103 | 5 | C0086237 | |
| Disease | Awakening Epilepsy | 1.04e-05 | 82 | 103 | 5 | C0751111 | |
| Disease | Aura | 1.04e-05 | 82 | 103 | 5 | C0236018 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 1.15e-05 | 13 | 103 | 3 | C0751122 | |
| Disease | Renal carnitine transport defect | 1.21e-05 | 2 | 103 | 2 | C0342788 | |
| Disease | Early Infantile Epileptic Encephalopathy 6 | 1.21e-05 | 2 | 103 | 2 | C4551549 | |
| Disease | MMR-related febrile seizures | 1.82e-05 | 15 | 103 | 3 | EFO_0006519 | |
| Disease | Neuralgia, Supraorbital | 2.24e-05 | 16 | 103 | 3 | C0038870 | |
| Disease | Neuralgia | 2.24e-05 | 16 | 103 | 3 | C0027796 | |
| Disease | Neuralgia, Atypical | 2.24e-05 | 16 | 103 | 3 | C0234247 | |
| Disease | Neuralgia, Stump | 2.24e-05 | 16 | 103 | 3 | C0234249 | |
| Disease | Neuralgia, Iliohypogastric Nerve | 2.24e-05 | 16 | 103 | 3 | C0423712 | |
| Disease | Neuralgia, Perineal | 2.24e-05 | 16 | 103 | 3 | C0423711 | |
| Disease | Paroxysmal Nerve Pain | 2.24e-05 | 16 | 103 | 3 | C0751373 | |
| Disease | Nerve Pain | 2.24e-05 | 16 | 103 | 3 | C0751372 | |
| Disease | Neuralgia, Ilioinguinal | 2.24e-05 | 16 | 103 | 3 | C0751371 | |
| Disease | Neuralgia, Vidian | 2.24e-05 | 16 | 103 | 3 | C0042656 | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 3.24e-05 | 18 | 103 | 3 | HP_0002373 | |
| Disease | B Virus Infection | 3.61e-05 | 3 | 103 | 2 | C0037140 | |
| Disease | Benign familial infantile epilepsy | 3.61e-05 | 3 | 103 | 2 | cv:C5575231 | |
| Disease | Postherpetic neuralgia | 3.61e-05 | 3 | 103 | 2 | C0032768 | |
| Disease | Herpesviridae Infections | 3.61e-05 | 3 | 103 | 2 | C0019372 | |
| Disease | Primary Erythermalgia | 3.61e-05 | 3 | 103 | 2 | C0014805 | |
| Disease | sick sinus syndrome (implicated_via_orthology) | 3.61e-05 | 3 | 103 | 2 | DOID:13884 (implicated_via_orthology) | |
| Disease | PAROXYSMAL EXTREME PAIN DISORDER | 3.61e-05 | 3 | 103 | 2 | C1833661 | |
| Disease | glycogen storage disease (implicated_via_orthology) | 7.21e-05 | 4 | 103 | 2 | DOID:2747 (implicated_via_orthology) | |
| Disease | tyrosine-protein kinase TEC measurement | 7.21e-05 | 4 | 103 | 2 | EFO_0020830 | |
| Disease | Brugada Syndrome (disorder) | 7.93e-05 | 24 | 103 | 3 | C1142166 | |
| Disease | Involutional paraphrenia | 8.98e-05 | 25 | 103 | 3 | C1571983 | |
| Disease | Psychosis, Involutional | 8.98e-05 | 25 | 103 | 3 | C1571984 | |
| Disease | Involutional Depression | 8.98e-05 | 25 | 103 | 3 | C0011574 | |
| Disease | Nonorganic psychosis | 1.02e-04 | 69 | 103 | 4 | C0349204 | |
| Disease | EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1 | 1.79e-04 | 6 | 103 | 2 | C3463992 | |
| Disease | Familial benign neonatal epilepsy | 1.79e-04 | 6 | 103 | 2 | C0220669 | |
| Disease | Congenital Pain Insensitivity | 2.51e-04 | 7 | 103 | 2 | C0002768 | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 5 | 2.51e-04 | 7 | 103 | 2 | C0020075 | |
| Disease | hepatitis C virus infection, cirrhosis of liver | 2.51e-04 | 7 | 103 | 2 | EFO_0001422, EFO_0003047 | |
| Disease | Mental Depression | 2.73e-04 | 254 | 103 | 6 | C0011570 | |
| Disease | Bipolar Disorder | 2.74e-04 | 477 | 103 | 8 | C0005586 | |
| Disease | Brugada syndrome | 3.33e-04 | 8 | 103 | 2 | cv:C1142166 | |
| Disease | Early Childhood Epilepsy, Myoclonic | 3.33e-04 | 8 | 103 | 2 | C0393695 | |
| Disease | Idiopathic Myoclonic Epilepsy | 3.33e-04 | 8 | 103 | 2 | C0338478 | |
| Disease | Symptomatic Myoclonic Epilepsy | 3.33e-04 | 8 | 103 | 2 | C0338479 | |
| Disease | X-linked infantile spasms | 3.33e-04 | 8 | 103 | 2 | C4552072 | |
| Disease | Benign Infantile Myoclonic Epilepsy | 3.33e-04 | 8 | 103 | 2 | C0751120 | |
| Disease | Myoclonic Encephalopathy | 3.33e-04 | 8 | 103 | 2 | C0438414 | |
| Disease | Myoclonic Absence Epilepsy | 3.33e-04 | 8 | 103 | 2 | C0393703 | |
| Disease | Pruritus | 3.33e-04 | 8 | 103 | 2 | C0033774 | |
| Disease | Tremor, Neonatal | 4.28e-04 | 9 | 103 | 2 | C0235843 | |
| Disease | Tremor, Perioral | 4.28e-04 | 9 | 103 | 2 | C0235078 | |
| Disease | Nerve Tremors | 4.28e-04 | 9 | 103 | 2 | C0235083 | |
| Disease | Tremor, Limb | 4.28e-04 | 9 | 103 | 2 | C0235081 | |
| Disease | Tremor, Muscle | 4.28e-04 | 9 | 103 | 2 | C0235082 | |
| Disease | Senile Tremor | 4.28e-04 | 9 | 103 | 2 | C0149840 | |
| Disease | Pill Rolling Tremor | 4.28e-04 | 9 | 103 | 2 | C0751564 | |
| Disease | Tremor, Semirhythmic | 4.28e-04 | 9 | 103 | 2 | C0751565 | |
| Disease | Action Tremor | 4.28e-04 | 9 | 103 | 2 | C0234376 | |
| Disease | Passive Tremor | 4.28e-04 | 9 | 103 | 2 | C0234377 | |
| Disease | Static Tremor | 4.28e-04 | 9 | 103 | 2 | C0234378 | |
| Disease | Resting Tremor | 4.28e-04 | 9 | 103 | 2 | C0234379 | |
| Disease | Intermittent Tremor | 4.28e-04 | 9 | 103 | 2 | C0234372 | |
| Disease | Fine Tremor | 4.28e-04 | 9 | 103 | 2 | C0234373 | |
| Disease | Coarse Tremor | 4.28e-04 | 9 | 103 | 2 | C0234374 | |
| Disease | Massive Tremor | 4.28e-04 | 9 | 103 | 2 | C0234375 | |
| Disease | Persistent Tremor | 4.28e-04 | 9 | 103 | 2 | C0234370 | |
| Disease | Continuous Tremor | 4.28e-04 | 9 | 103 | 2 | C0234371 | |
| Disease | Darkness Tremor | 4.28e-04 | 9 | 103 | 2 | C0234381 | |
| Disease | Involuntary Quiver | 4.28e-04 | 9 | 103 | 2 | C1527384 | |
| Disease | Saturnine Tremor | 4.28e-04 | 9 | 103 | 2 | C0040827 | |
| Disease | Myoclonic Epilepsy | 4.28e-04 | 9 | 103 | 2 | C0014550 | |
| Disease | Colorectal Neoplasms | 4.33e-04 | 277 | 103 | 6 | C0009404 | |
| Disease | Psychotic Disorders | 4.41e-04 | 101 | 103 | 4 | C0033975 | |
| Disease | Epilepsy, Myoclonic, Infantile | 5.33e-04 | 10 | 103 | 2 | C0917800 | |
| Disease | cannabis dependence measurement | 6.37e-04 | 48 | 103 | 3 | EFO_0008457 | |
| Disease | Other specified cardiac arrhythmias | 6.50e-04 | 11 | 103 | 2 | C0348626 | |
| Disease | Nodal rhythm disorder | 6.50e-04 | 11 | 103 | 2 | C0264893 | |
| Disease | Ectopic rhythm | 6.50e-04 | 11 | 103 | 2 | C1399226 | |
| Disease | Tremor | 6.50e-04 | 11 | 103 | 2 | C0040822 | |
| Disease | CARDIAC CONDUCTION DEFECT, NONSPECIFIC (disorder) | 6.50e-04 | 11 | 103 | 2 | C2748542 | |
| Disease | Myoclonic Astatic Epilepsy | 6.50e-04 | 11 | 103 | 2 | C0393702 | |
| Disease | cholestasis (biomarker_via_orthology) | 6.77e-04 | 49 | 103 | 3 | DOID:13580 (biomarker_via_orthology) | |
| Disease | Colorectal Carcinoma | 7.98e-04 | 702 | 103 | 9 | C0009402 | |
| Disease | glycochenodeoxycholate glucuronide (1) measurement | 9.18e-04 | 13 | 103 | 2 | EFO_0800474 | |
| Disease | X-24588 measurement | 9.18e-04 | 13 | 103 | 2 | EFO_0800898 | |
| Disease | Brugada Syndrome 1 | 9.18e-04 | 13 | 103 | 2 | C4551804 | |
| Disease | P wave duration | 1.23e-03 | 15 | 103 | 2 | EFO_0005094 | |
| Disease | Sinus Node Dysfunction (disorder) | 1.23e-03 | 15 | 103 | 2 | C0428908 | |
| Disease | Tremor, Rubral | 1.40e-03 | 16 | 103 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 1.40e-03 | 16 | 103 | 2 | C0750937 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IGAFSMNLYTVYIIK | 81 | P08173 | |
| VILVREKATGRYYAM | 166 | P31751 | |
| IANIMKTLAYRGFIF | 316 | O43414 | |
| RGTQVYDGKFAIFVM | 106 | P21860 | |
| KIGMSRFQTYITYFV | 246 | Q8N8Q8 | |
| GKNLFAMVVEGVVYF | 1876 | P78363 | |
| TFKYRISVGAPVYMA | 36 | Q9P0M6 | |
| RAGVQIAIMTFKDYF | 131 | Q9GZX7 | |
| ILKYMSRVLFVYDVG | 341 | Q9UGM1 | |
| FGYFILGTVVNKTLM | 191 | O14678 | |
| FGVVVYRLVVMEQFA | 566 | Q9BYT9 | |
| DYLVMIIVRGFGFQI | 946 | Q96T37 | |
| AVFGKYGRIVEVLLM | 26 | P38159 | |
| MTRVYYKEAVGAFVV | 91 | Q13637 | |
| VTGVKFRTGIMGVIY | 376 | O15438 | |
| FRTGIMGVIYRKALV | 381 | O15438 | |
| RKVMYFLVTFGEGVE | 136 | P47874 | |
| IYRQGVKVAISAIYM | 241 | Q86TP1 | |
| TVYFKGGKYMQAVIQ | 276 | Q13451 | |
| IVFTAVYVFIIIGNM | 31 | Q9GZK7 | |
| FGNFLVMYVIVRYTK | 86 | P35372 | |
| LSYFKFIGRVAGMAV | 1051 | P46934 | |
| SYYRTIKGFMVLIEK | 356 | Q9Y217 | |
| TMIDIFKYVIYGIAA | 76 | P51674 | |
| FIVLLMIRYKVYGDG | 551 | Q9P244 | |
| FSVLSGKVMVREIYY | 76 | Q2LD37 | |
| KLIYDAGVAFVVIMF | 186 | O75387 | |
| FVGIFLGKLRMVADY | 701 | Q9P1W3 | |
| VTVMGLTFIYRFGKN | 251 | Q9Y5P1 | |
| AVTRMGIYVGAKVFL | 36 | P17858 | |
| VVRMGIYVGAKVYFI | 46 | Q01813 | |
| VRISGRGFCVKMFYI | 91 | O14960 | |
| VVQTVLFIGYIMYRS | 486 | P49257 | |
| EVFGYLAKYTVPVMR | 141 | Q93074 | |
| VAIVGLYRTGKSYLM | 41 | P32455 | |
| VAIVGLYRTGKSYLM | 41 | P32456 | |
| VAIVGLYRTGKSYLM | 41 | Q9H0R5 | |
| VAIVGLYRTGKSYLM | 56 | Q96PP9 | |
| VAIVGLYRTGKSYLM | 41 | Q96PP8 | |
| VAIVGLYRTGKSYLM | 41 | Q6ZN66 | |
| VAIVGLYRTGKSYLM | 41 | Q8N8V2 | |
| VMTIFFNVSRRFGYV | 266 | P78334 | |
| VGIFLDVGMRSIAFY | 216 | A6NLU0 | |
| RQKIVFVIFLIFYMG | 21 | Q6IEV9 | |
| YIIREGTIGKKMYFI | 621 | Q9Y3Q4 | |
| VRIGMTRKFGYVDFE | 341 | P19338 | |
| VGIKYMGVFTYVLVL | 201 | Q9Y6A1 | |
| FVGVNMYGVFVRILT | 221 | Q08828 | |
| YIIREGAVGKKMYFI | 501 | O60741 | |
| IYAVIGMQVFGKIAL | 1421 | Q13936 | |
| RGLRVDKTVYMVGSY | 156 | Q99819 | |
| GRRVVSGAYDFMVKV | 511 | Q969H0 | |
| KVRYFGKGYMVVLRL | 116 | Q9BQA9 | |
| VEPMKFVYRGRIAVF | 816 | Q9Y2E4 | |
| YIFIFVIGMIANSVV | 51 | P25106 | |
| GKKYGFTLRAIRVYM | 1111 | Q6P0Q8 | |
| KFMIRIGVFSILYLV | 416 | Q9NPG1 | |
| VEPMKFVYRGRIAVF | 831 | Q14689 | |
| YEMIFRGTGALIFVI | 131 | Q9NQL2 | |
| YLATVLVMVGKFGVT | 426 | O76082 | |
| AFVTKGVYMLKAVIY | 406 | Q8TDX9 | |
| FIMGSVILYGFLVAK | 1756 | Q8TDX9 | |
| MIIFRFIYGKDVFEA | 591 | Q13620 | |
| FIGGIKIFLLTVMAY | 106 | Q8NGN0 | |
| VGTYIKYQVAKMVQG | 266 | Q5VU65 | |
| GVTIFYGTMIFTYLK | 246 | Q8NGG4 | |
| GVEFRTLMKAYGIRF | 306 | Q93086 | |
| VGIFLDVGMRSIAFY | 216 | F8VTS6 | |
| VLYGVFLYMGVSSLK | 1036 | Q9Y6M7 | |
| LRAAGKTYMIFFVVI | 416 | P35499 | |
| KTYMIFFVVIIFLGS | 421 | P35499 | |
| VLKMLALRQYYFTVG | 1401 | P35499 | |
| GVVKVSDFGMARYVL | 501 | P42680 | |
| AYLPAVVMVGRYFQK | 141 | Q7RTX9 | |
| AVVYFISVLMVSKYR | 1566 | Q8NFP9 | |
| LRAAGKTYMIFFVVV | 371 | Q15858 | |
| KTYMIFFVVVIFLGS | 376 | Q15858 | |
| SIYKFGRIEVNMFIG | 216 | Q9H5Q4 | |
| HGFIYFVDGTMIRKI | 1316 | Q9UKZ4 | |
| AGKTYMIFFVLVIFL | 396 | Q9NY46 | |
| IRVVYRRESMFGFFK | 46 | Q6ZT89 | |
| FTAHMAYRKGIILFI | 131 | Q9Y399 | |
| FMTLVVFVGVKYVNK | 261 | Q9UP95 | |
| LEVVGVVYVYGMKRF | 486 | Q96N87 | |
| GKTYMIFFVLVIFLG | 396 | P35498 | |
| LIFMTYVISFIFRKG | 1116 | O94911 | |
| GIMQTVKGFFYVSLL | 911 | Q86XI2 | |
| FFRVGFVVAERVLYM | 401 | Q8IUR5 | |
| GTIGFYAAYMFVRKI | 621 | Q92544 | |
| IKGVTLGFRYKMRSV | 81 | P32969 | |
| LRTSGKIYMIFFVLV | 366 | Q9Y5Y9 | |
| YAISAVYFAGVMVRL | 446 | Q8TCJ2 | |
| VIGFALGSLFAKMYV | 221 | Q9NPD5 | |
| IQYVVEFAKRITGFM | 281 | Q92753 | |
| AAGKTYMIFFVLVIF | 396 | Q99250 | |
| IVILVSFGLFMYAKR | 31 | Q96E16 | |
| MGLYASVVLVIGKFV | 2671 | Q9H5I5 | |
| GKVVYVTATFPYIML | 251 | P48066 | |
| RAAGKTYMIFFVLVI | 381 | Q9UQD0 | |
| RYKVGFMKTGTVVAL | 846 | P47989 | |
| VLVGYKAVYRISFAM | 91 | Q13530 | |
| FKIAALIGIMVGSFY | 136 | Q13530 | |
| MAFRLTGGTKDYIVV | 66 | Q15393 | |
| GYFLIRGVMTLFSIK | 416 | Q99835 | |
| GGRKFDLRVYVLVMS | 221 | Q3SXZ7 | |
| QILYASGKVYMIFFV | 361 | Q01118 | |
| GMFIVVSFAGRLVVY | 586 | Q92508 | |
| VSFAGRLVVYKIVYM | 591 | Q92508 | |
| MGLYVSIVLVIGKFV | 2441 | Q92508 | |
| GIVDFFRQYVMLIAV | 86 | Q4V9L6 | |
| KSSFQRVAGVYLFMI | 281 | P48651 | |
| SVYFREIGGLMFVKN | 51 | Q8NA31 | |
| KGIMTQRFVVKFLSY | 411 | Q96GX1 | |
| FMKVLPAVGISYVVY | 451 | Q6NUK1 | |
| KVRMYSRTVAIIGGF | 106 | Q96IK0 | |
| FVMFGVLTIAVRIYH | 96 | A6NI61 | |
| GDKAARAVVYFVAMV | 66 | Q9UPR5 |